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Abstract 
Although research on Autism Spectrum Disorder (ASD) continues to increase, there is 
not yet a “cure” for the disorder. There is a lack of consensus regarding most effective 
treatments, much less an accepted treatment plan or course. Families may feel alone and lost in 
the treatment decision process. In order to best assist caregivers, psychologists must understand 
the selections caregivers make, their sources of information, and what influences them in their 
decision-making process. With this knowledge, clinicians may best effect change in caregiver 
choice by encouraging informed decision-making and use of empirically-based interventions. 
Thus, the purpose of the current study was to examine the choices that caregivers make in 
terms of treatment for their children with ASD, the sources from which they obtain 
information about interventions, and the child and caregiver characteristics that predict 
evidence-based practice versus complementary and alternative medicine use. Caregivers of 
children or adolescents with ASD completed an online survey that included questions about these 
factors and a parent-report measure of ASD symptom severity.  Results of treatment selections and 
sources of information were fairly consistent with extant research. However, the results of 
regression analyses indicated that only respondent education statistically significantly 
contributed to predicting hours of CAM treatment, whereas only subject symptom severity of 
ASD statistically significantly contributed to predicting hours of EBP treatments. Additional 
results, discussion, future directions, and limitations of the study are provided.   
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Introduction 
Autism Spectrum Disorder (ASD) is a neurobehavioral disorder that affects 1 out of 68 
children in the United States according to recent estimates (Center for Disease Control, 2014). 
The syndrome is characterized by core deficits of socialization and communication, as well as 
the presence of repetitive behavior, restricted interests, and sensory issues (Brereton, Tonge, 
& Einfeld, 2006; Fodstad, Matson, Hess, & Neal, 2009; J. L. Matson & Dempsey, 2009; 
Tidmarsh & Volkmar, 2003). Autism has become an increasingly studied topic over the past 
few decades due to the rising number of diagnoses throughout the world (Conrad & Tan, 
2014). Despite additional focus on the disorder, much about ASD remains unknown. 
In the forefront of ASD research is the topic of intervention. At present, a “cure” has 
yet to be determined (Bölte, 2014). As such, professionals and affected families seek the most 
effective options to decrease social and language problems, idiosyncratic behaviors, and 
comorbid issues. Treatment of these issues subsequently improves the quality of life of the 
individual and his or her support network. However, information available to caregivers varies 
in quality and accuracy, with different sources making conflicting claims about the numerous 
current intervention options (Stephenson, Carter, & Kemp, 2012). 
Caregivers of children with ASD employ a variety of interventions, including those with 
less empirical support and those methods that have been proven to be potentially harmful to 
individuals with ASD. As professionals assigning diagnoses and serving as a major source of 
information, clinical psychologists would be well served to investigate why this is occurring 
and how this pattern can be changed. In doing so, the amount of time between diagnosis of 
ASD and start of effective, data-based intervention can be decreased. The earlier that risk for 
ASD is identified and effective intervention begun, the greater the chance to guide an abnormal 
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trajectory toward a neurotypical pathway of brain and behavioral development (Dawson, 
2008). 
The purpose of the present study is to use an original, caregiver-reported Internet 
survey to ascertain information about a number of facets of autism intervention. The authors 
wish to find not only what intervention options are chosen, but also what factors among the 
children and adolescents and among the caregivers themselves that impact choice. The present 
document describes the examination of caregiver intervention choice and influences on these 
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Autism Treatment Options 
Caregivers generally engage in a variety of autism interventions concurrently, both 
evidence-based and not (Green et al., 2006). Knowledge about the types of treatments 
available, their efficacy, and their popularity among caregivers allows professionals to more 
effectively collaborate with and guide intervention decisions, thereby providing support and 
enhanced outcomes (Mire, Raff, Brewton, & Goin-Kochel, 2015). A discussion of the use of 
evidence- based practice and complementary and alternative medicine in the field of autism 
follows. 
Evidence-Based Practice for Autism 
Evidence-based practice (EBP) is atheoretical and aims to improve performance 
outcomes by basing treatment on objective and scientifically credible evidence (Ollendick & 
King, 2004). The current study uses the strength of evidence categorizations from the recent 
second phase of the National Standards Project by the National Autism Center out of May 
Institute (National Autism Center, 2015). Using these categorizations, treatments can be 
considered established, emerging, or unestablished. Interventions categorized as established 
have sufficient evidence available to confidently determine that an intervention produces 
favorable outcomes for individuals on the autism spectrum. Emerging interventions have one 
or more studies that suggest favorable outcomes for individuals with ASD, but additional high 
quality studies must consistently show this outcome before firm conclusions about intervention 
effectiveness can be drawn. Finally, interventions categorized as unestablished have little or no 
evidence to allow firm conclusions about intervention effectiveness among individuals with 
ASD to be drawn, and additional research may show the intervention to be effective, 
ineffective, or harmful (National Autism Center, 2015). In considering a treatment, including 
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those categorized as established, psychologists should continually question treatment 
components, client characteristics that predict success, and mechanisms of change (Ollendick 
& King, 2004). Category assignments are fluid and change as research is conducted (Ollendick 
& King, 2004). 
Using the National Autism Center’s categorizations, for persons with autism under 22 
years of age, there are 14 established interventions, 18 emerging interventions, and 13 
unestablished interventions. Results of this project for individuals with autism over 22 years of 
age are beyond the scope of the current study. The 14 established interventions are: Behavioral 
Interventions, Cognitive Behavioral Intervention Package, Comprehensive Behavioral 
Treatment For Young Children, Language Training (Production), Modeling, Natural Teaching 
Strategies, Parent Training, Peer Training Package, Pivotal Response Training (PRT), 
Schedules, Scripting, Self-Management, Social Skills Package, And Story-Based Intervention. 
These treatments will be discussed in the following sections. 
Practitioners may combine EBP options based on their professional judgment and 
clinical expertise to address the individual needs of their clients (C. Wong et al., 2015). Many  
researchers and clinicians use a continuum of teaching approaches that vary by individual. 
Ultimately, use of these different strategies should not be arbitrary but rather determined by 
individual response to intervention. 
Applied behavior analysis (ABA). Several of the below National Standard Project’s 
established interventions are either entirely or partially based on ABA, warranting a brief 
discussion of the science. Interventions based on the principles of Applied Behavior Analysis 
(ABA) have garnered the most empirical support and thus have been identified as the 
treatment of choice for ASD (Vismara & Rogers, 2010; C. Wong et al., 2015). A common 
	   5 
misconception among laypersons is that ABA is a treatment itself. In actuality, ABA is a 
science of analyzing how changes in the environment affect behavior (Schreibman et al., 
2015). Goals of ABA include teaching new skills, promoting generalization of emerging 
skills, and decreasing challenging behavior (Weitlauf et al., 2014). This is accomplished in the 
use of multiple empirically based practices founded on operant learning procedures 
(Schreibman et al., 2015). 
Structured ABA has been developed into comprehensive programs that primarily 
utilize discrete trial training (DTT) of skills as determined by a professional. DTT is an 
example of operant learning in which skills are separated into components that are taught using 
massed trials of antecedent-behavior-consequence sequences initiated by the therapist (Landa, 
2007; Schreibman et al., 2015). Due to some issues with regimented DTT (e.g., lack of 
generalization of skills, presence of escape-maintained challenging behavior, overdependence 
on prompts), research has progressed toward expanding the use of ABA to methods that may 
decrease the likelihood of these problems (Schreibman et al., 2015). Additionally, research on 
typical and atypical childhood development revealed a discrepancy between early learning 
theory and DTT (Schreibman et al., 2015). 
As such, Naturalistic Developmental Behavioral Interventions (NDBI) were developed 
to make use of natural contingencies and engage children within developmental sequences,  
allowing them to connect novel experiences with prior learning (Schreibman et al., 2015). This 
is accomplished by choosing target skills that are within a child’s “zone of proximal 
development” and by reinforcing child-initiated behaviors that contribute to learning of 
targeted skills (Schreibman et al., 2015). Using natural contexts increases the likelihood that 
new skills generalize to other settings (Schreibman et al., 2015). 
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At present, there have not yet been any published large scale randomized controlled 
trials (RCT) comparing DTT and NDBIs (Schreibman et al., 2015). Nevertheless, NDBIs are 
ABA- based interventions supported by a large body of evidence (Schreibman et al., 2015). 
Evidence- based features of NDBIs include the three-part contingency (antecedent-response-
consequence), manualized practice, fidelity of implementation assessments, individualized 
treatment goals, ongoing measurement of progress, child-initiated teaching episodes (i.e., child 
choice), environmental arrangement to cause child initiation or interaction with the treatment 
provider, natural reinforcement and motivation enhancement, prompting and prompt fading, 
reciprocal interactions (i.e., shared control or turn-taking), modeling, adult imitation of child 
behavior, and normalizing the child’s attentional focus (Schreibman et al., 2015). Some of the 
most researched models of NDBI include: incidental teaching, PRT, Early Start Denver Model 
(ESDM), enhanced milieu teaching, reciprocal imitation training, Project ImPACT, Joint 
Attention Symbolic Play Engagement and Regulation (JASPER), Social 
Communication/Emotional Regulation/Transactional Support (SCERTS), and Early 
Achievements (Schreibman et al., 2015). 
Established interventions per National Standards Project 
Behavioral interventions. Behavioral interventions include antecedent and consequent 
packages. These interventions can be, but do not have to be, based on ABA. Studies of 
behavioral interventions included a single component or multiple components and targeted a 
wide array of behaviors. Targets of interventions ranged from social and communication 
deficits to behavioral excesses including stereotypy or challenging behavior. Examples of 
interventions consisting of only one identified component reportedly used joint attention 
intervention, chaining, imitation training, reinforcement schedule, standard echoic training, etc. 
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in isolation (National Autism Center, 2015). For instance, Baltruschat et al. (2011) used 
positive reinforcement to improve central-executive working memory abilities as measured by 
a counting span task. A single strategy was also used by Bartlett, Rapp, Krueger, and 
Henrickson (2011); the authors found that response cost was effective in reducing spitting 
exhibited by a child with ASD. Other behavioral interventions that the project included 
encompassed two or more identified components, such as a package that included prompt 
delay, auditory scripts, manual prompts, behavioral rehearsal, and tokens (National Autism 
Center, 2015). For instance, Stokes, Cameron, Dorsey, and Fleming (2004) used a 10-step task 
analysis, general case instruction, and correspondence training to teach personal hygiene 
behaviors. 
Cognitive behavioral intervention package (CBIP). CBIP is now considered 
established for persons with autism. CBIPs include identifying and describing emotions and 
associated physical responses, cognitive restructuring, homework, and parent sessions 
(National Autism Center, 2015). Manualized programs (e.g., Coping Cat, Exploring Feelings) 
have been adapted for audiences with ASD and target co-occurring symptoms, such as anxiety 
or anger (National Autism Center, 2015). For example, cognitive behavioral therapy (CBT) 
has a strong evidence base for improvements in anxiety among school-aged, high functioning 
children with comorbid anxiety symptoms (Weitlauf et al., 2014). 
Comprehensive behavioral treatment for young children. Comprehensive 
behavioral treatment for young children include interventions described as ABA, Early 
Intensive Behavioral Intervention (EIBI), or behavioral inclusive programs (National Autism 
Center, 2015). These are intensive services (e.g., 25-40 hours per week for 2-3 years) based on 
ABA (National Autism Center, 2015). Strategies include DTT, incidental teaching, errorless 
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learning, behavioral momentum, shaping, modeling, and other ABA foundational strategies 
(National Autism Center, 2015). Programs are individualized to the client. 
EIBI results in positive outcomes for young children with ASD in terms of cognitive 
functioning, communication skills, adaptive behavior, and educational placement 
(Dillenburger, 2014; Estes et al., 2015; Peters-Scheffer, Didden, Korzilius, & Sturmey, 2011; 
Weitlauf et al., 2014). Researchers of EIBI have demonstrated that intervention started at 
preschool age and sustained for several years results in positive change among many children 
with ASD (Dawson, 2008). In their review of early intensive behavioral and developmental 
interventions, Weitlauf et al. (2011) identified 25 unique studies including use of 
UCLA/Lovaas-based interventions, ESDM, Learning Experiences and Alternate Program for 
Preschoolers and their Parents (LEAP) program, and eclectic variants. The authors found that 
improvements were most often reported in cognitive and language abilities, with fewer positive 
results for adaptive skills, core ASD symptom severity, and social functioning. Some better 
quality studies included reports of improvements in symptom severity, but overall, the 
reviewers considered evidence for these outcomes as limited and mixed. In particular, they 
noted that studies delivering low-intensity interventions have not resulted in the substantial 
gains that more intensive options have. Despite promising evidence for these intensive 
interventions, long-term effects have not been studied sufficiently to determine if 
improvements persist over development (Weitlauf et al., 2014). 
Another area necessitating further research is optimal treatments based on age. Thus 
far, EBP for autism has primarily been studied among 3 to 11 year olds, with fewer treatments 
studied among toddler/infant, high school, and older age groups (Mire et al., 2015). Given the 
growing evidence that supports diagnosis as early as infancy (Dover & Le Couteur, 2007; 
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Klaiman, Fernandez-Carriba, Hall, & Saulnier, 2015; Zwaigenbaum, Bryson, & Garon, 2013), 
research on early intervention is of particular importance. In order to achieve greatest 
treatment gains, techniques need to be designed and adapted for younger intervention 
recipients (Dawson, 2008; Landa, 2007). As such, recently focus has shifted to incorporating 
developmental orientations into traditional ABA-based interventions (Schreibman et al., 
2015). That is, tailoring behavioral interventions that have proven effective among older 
children to the developmental level of 2 and 3 year olds. This approach has spawned increased 
interest in methods that are more naturalistic and less regimented but that still meet 
requirements of ABA, such as making treatment less structured (Schreibman et al., 2015). 
Intervention may take place during  interactive social contexts (e.g., play, daily routines) and 
involve child-directed teaching (e.g., use of preferred items) (Schreibman et al., 2015). These 
changes make intervention better suited for recipients of early intervention. 
Language training (production). Language training for production uses a variety of 
methods to elicit verbal communication, including modeling for imitation, prompting, cue-
pause- point, music, and reinforcement (National Autism Center, 2015). These components are 
commonly presented in a multi-component package format. For instance, a language package 
consisting of noncontingent reinforcement and repeated verbal modeling increased 
independent requests and word approximations (Ganz, Flores, & Lashley, 2011). Other 
procedures may be used in isolation. For instance, the cue-pause-point procedure is used to 
teach individuals who exhibit persistent immediate echolalia “to remain quiet when the trainer 
[holds] up his index finger before, during, and briefly after the presentation of targeted 
questions and then to use a pre-trained verbal label as the correct response when the trainer 
[points] to the appropriate environmental cue” (McMorrow, Foxx, Faw, & Bittle, 1987, p.11). 
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This particular strategy has been found effective in promoting functional use of verbal labeling 
repertoires and in decreasing echolalia of instructions (i.e., including “say” following a “say 
[word]” instruction) (McMorrow et al., 1987; Valentino, Shillingsburg, Conine, & Powell, 
2012). 
Modeling. Modeling involves teaching by showing the targeted skill, allowing for 
imitation. This task can be accomplished in the presence of the individual with ASD (live) or 
by delivering a pre-recorded video of the target behavior to be imitated. Instructional 
modeling, which involves a therapist demonstrating expected behaviors, complements the 
visual processing abilities of persons with ASD (McCoy & Hermansen, 2007). The subject of 
video modeling can be an adult, a peer, or the client, either by self-modeling or point-of-view 
modeling (McLay, Carnett, van der Meer, & Lang, 2015). Each of these approaches has 
proven effective to teach skills to children with ASD (McCoy & Hermansen, 2007). Following 
the imitation behavior, the therapist may provide feedback on accuracy and appropriateness of 
the client’s response, as well as additional suggestions for further improvement (J. Matson, 
Matson, & Rivet, 2007). 
Naturalistic teaching strategies. Naturalistic teaching strategies are a variety of 
methods to increase adaptive skills across settings. These strategies include focused 
stimulation, incidental teaching, milieu teaching, embedded teaching, responsive education, 
and prelinguistic milieu teaching (National Autism Center, 2015). These methods, which stem 
from a behavioral perspective, have significant evidence for promoting functional language 
skills using direct prompting and reinforcement (Ingersoll, 2011). Incidental teaching, for 
example, is a naturalistic language intervention that aims to increase spoken language within 
adult-child interactions. This goal can be accomplished by structuring the setting to encourage 
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the child to initiate interaction (e.g., requesting help reaching a preferred item) using indirect, 
environmental prompting (McDuffie, 2013). Methods are frequently child-directed but 
structured by the therapist and include materials and consequences the child would naturally 
encounter (National Autism Center, 2015). 
Parent training packages. Parent training packages include the use of caregivers to 
provide a therapeutic environment for individuals with autism. Training can be in-vivo 
individual or group training, support groups with educational components, or training manuals 
(National Autism Center, 2015). Skills taught may include strategies to encourage imitation, 
joint attention, expectant waiting to elicit communication, etc. (National Autism Center, 2015). 
Professionals may provide instruction on behavior management skills, which has been shown 
to decrease challenging behaviors when used by caregivers (Osborne, McHugh, Saunders, & 
Reed, 2008a). Parents may also serve as a therapist to deliver EIBI or other ABA-based 
therapy (M. L. Matson, Mahan, & Matson, 2009), filling the need for therapy in a high-
demand context and/or increasing the number of hours of evidence-based therapy a child is 
able to receive. Advantages of parent training beyond availability of treatment include greater 
generalization of skills, less expensive and resource intensive options, and increased likelihood 
of maintenance of treatment gains (M. L. Matson et al., 2009). 
Peer training packages. Peer training packages include facilitation of social skill 
growth across settings using the child’s peers. Strategies should include teaching peers how to 
gain the child’s attention, facilitate sharing, provide help, model appropriate play skills, etc., 
then allowing the peers to practice with the children with ASD in the presence of a group 
instructor who can provide feedback (National Autism Center, 2015). This approach includes 
Project LEAP, peer networks, circle of friends, buddy skills package, integrated play groups, 
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peer initiation training, peer-mediated social interaction training, etc. (National Autism Center, 
2015). In order to increase benefits, programs should include academic and social mediation, 
peer groups across settings, and involvement of novel peers to test newly acquired skills 
(Kamps et al., 2002). Generalization of targeted social skills leads to social interaction 
becoming more naturally reinforcing for children with ASD, which subsequently increases the 
likelihood the targeted social skills will be exhibited by participants (Kamps et al., 2002). 
Pivotal Response Treatment. Pivotal Response Treatment (PRT; aka Pivotal 
Response Training, Pivotal Response Teaching, and the Natural Language Paradigm), based 
on ABA, is a naturalistic approach that targets “’pivotal’ behaviors related to motivation to 
engage in social communication, self-initiation, self-management, and responsiveness to 
multiple cues” (National Autism Center, 2015, p. 59). Parent involvement and implementation 
across natural settings with direct natural consequences are key components. Such programs 
include child-choice, reinforcing attempts at target skills, incorporating new and mastered 
tasks into the program, and generalization (National Autism Center, 2015). 
Recently, Mohammadzaheri, Koegel, Rezaee, and Rafiee (2014) conducted a RCT to 
compare PRT and structured ABA among children ages 6 to 11 years. They aimed to determine 
whether therapist- vs. client-led trials led to greater gains in social communication domains, as 
measured by mean length of utterance in a speech sample and by a standardized 
communication checklist completed by teachers and parents. They found that their PRT 
intervention was more effective in terms of gains in social communication skills than their 
structured ABA intervention. The authors attributed this to components of child choice (e.g., 
preferred toys and activities), the natural play context, and the effect of motivational 
components (e.g., less escape-maintained disruptive behavior to interfere with intervention). 
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Schedules. Schedules come in many forms (e.g., pictures, written, 3D objects, digital 
assistance programs), but all identify activities for a time period and in a certain order, 
allowing children with ASD to increase their independence. They may be used in any setting 
and to section apart any activity (e.g., leisure time, self-care, housekeeping or educational 
tasks). For instance, visual activity schedules have been used to teach transition behavior and 
staying on- task, to reduce challenging behavior, and to promote social initiation, 
independent play tasks, and many other skills (Knight, Sartini, & Spriggs, 2014). Prerequisite 
skills include picture identification and/or reading ability (National Autism Center, 2015). 
Schedules may be incorporated with other methods, including graduated guidance and 
reinforcement schedules (Knight et al., 2014). 
Scripting. Scripting is verbal or written guidance for initiating or responding in a 
certain situation. Scripts are imitated and practiced before use, usually in conjunction with 
behavioral interventions, such as prompting or reinforcement (National Autism Center, 
2015). They may address topics such as responding to a greeting, describing a recent activity, 
or asking questions to gain information (R. Lee & Sturmey, 2014). Training to say scripted 
sentences results in greater frequency of initiations (R. Lee & Sturmey, 2014). Scripts are 
faded as mastery is obtained, allowing for greater independence, generalization, and 
spontaneity of speech (National Autism Center, 2015). 
Self-management strategies. Self-management strategies allow persons with ASD to 
increase independence and generalize new skills without constant supervision, typically by 
self- evaluating performance and self-delivering reinforcement (Vismara & Rogers, 2010). 
Targeted tasks are those in which supervision is not needed, accepted, or expected. Clients are 
taught to evaluate steps of an activity and deliver reinforcement independently. Therapists 
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provide prompts that are gradually faded. Reinforcement initially targets accuracy in 
monitoring rather than in task performance (National Autism Center, 2015). Self-management 
has been used across a variety of skill domains, including academic performance, conversation 
skills, stereotypy, and play (Vismara & Rogers, 2010). 
Social skills packages. Social skills packages teach skills necessary to meaningfully 
participate in social environments, including eye contact, gestures, recognizing facial 
expressions, reciprocating information, initiating or ending interaction with others, etc. This 
can be accomplished individually, in peer dyads, or in small groups. These packages generally 
include behavioral components (e.g., reinforcement, prompting, modeling) (National Autism 
Center, 2015). Social skills interventions vary widely in their procedures, scope, and intensity. 
As such, accumulating evidence to support use is difficult. Nonetheless, Weitlauf et al. (2011) 
reviewed two good-quality and ten fair-quality studies. These studies used peer- and group-
based approaches, emotion identification, and theory of mind training, among other methods. 
Most of the studies reported short-term improvement in directly tested or parent-rated social 
skills (e.g., emotion recognition). 
Story-based interventions. Story-based interventions (including Social Stories) use a 
written description of a target behavior, situations in which the behavior is appropriate, and 
potential outcomes. Stories may include comprehension questions to check for understanding 
(National Autism Center, 2015). The stories may promote appropriate behavior, discourage 
inappropriate behavior, or teach routines, skills, or coping with transitions and novel situations 
(Constantin, Pain, & Waller, 2013). Individualization of teaching materials should address the 
needs and skills of the client, including reading and comprehension abilities, learning style, 
attention, and preferred topics or interests (Constantin et al., 2013). 
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Complementary and Alternative Treatments for Autism 
Many individuals with ASD are exposed to health care approaches outside of 
mainstream or conventional medicine, either to replace standard medical care or as a 
supplement (Levy & Hyman, 2015). These options are known as complementary and 
alternative medical treatments (abbreviated as CAM). For ASD, CAM is reportedly used to 
treat core symptoms as well as comorbid conditions (e.g., attention, hyperactivity, 
gastrointestinal symptoms, seizures, sleep, sensory sensitivity (H. H. Wong & Smith, 2006)). 
CAM treatments develop as rapid responses to new scientific information, but these options 
have not been empirically tested for appropriate use prior to implementation (Levy & Hyman, 
2015). 
How do CAM treatments begin to gain popularity? For many intended to treat autism, 
early case reports indicated improvement after treatment, which triggered searches for a 
biological mechanism and additional studies. Small, uncontrolled studies resulted in some 
added support, occasioning continued use by encouraged families, followed by refutation of 
early positive results by scientifically rigorous trials (Akins, Angkustsiri, & Hansen, 2010). 
Despite this disproof of efficacy, there is a striking disparity between use of CAM for ASD 
and evidence to support its use (Brondino et al., 2015). In one survey, more than 70% of 
parents of children with ASD reported having used at least one CAM therapy (Christon, 
Mackintosh, & Myers, 2010; Hanson et al., 2007). 
Unfortunately, many caregivers do not have sufficient knowledge of potential side 
effects, yet they do not disclose use of CAM to health care providers (Levy & Hyman, 2015).            
Lack of disclosure may be due to shortage of time or perceived necessity for discussion, 
concern regarding the professionals’ judgment of their choices, and/or beliefs that the 
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professional is not sufficiently knowledgeable about the options (Akins et al., 2010; H. H. 
Wong & Smith, 2006). As a result, health care providers must routinely inquire about use of 
CAM treatments and encourage shared and informed decision-making. Professionals should 
discuss the efficacy and safety of CAM treatments, including possible interactions other 
treatments and medications (Brondino et al., 2015). Treatments with evidence of efficacy and 
safety should be suggested. Treatments that are expensive, interfere with evidence-based 
intervention, have little or no efficacy, and/or have high risk of harm should be discouraged by 
medical professionals (Akins et al., 2010; Brondino et al., 2015). Some clinicians believe that 
options falling between these categories can be tolerated if they are monitored closely for 
positive and negative outcomes (Akins et al., 2010). 
Fortunately, some organizations and professionals are combatting those treatment 
options that have little or no efficacy or have high risk of harm. For instance, the U.S. Food 
and Drug Administration (FDA) has threatened legal action against companies making false or 
misleading claims about autism treatments (e.g., hyperbaric oxygen therapy [HBOT], chelation, 
Miracle Mineral Solution, detoxifying clay baths, probiotic products; FDA, 2014). 
Additionally, their website offers tips to help caregivers spot potential scams. These include 
being skeptical of products that claim to treat a range of maladies or provide a “miracle cure.” 
As awareness of the importance of empirical basis for treatment use grows among 
caregivers, demand for accurate information should follow. However, data from 
methodologically sound studies need to accrue in order to elucidate what works and what does 
not. Biomedical and non-biomedical treatments for autism are considered non-EBP because of 
their lack of scientific support, either because support has not yet been gathered or because 
researchers have indicated the intervention does not result in positive outcomes. 
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As with the established treatments, the current study uses the National Standards 
Project, Phase 2 (National Autism Center, 2015) results to distinguish treatments that are 
considered non- EBP (i.e., CAM), whether labeled as emerging or unestablished. However, 
because of the large number of these interventions identified, the current paper does not include 
discussions of all of these treatments. Instead, the lists of identified emerging and unestablished 
interventions follow, with descriptions of the most popular (i.e., most endorsed by caregivers in 
extant research) or otherwise noteworthy (e.g., due to high risk of harm) provided afterward. 
Interventions categorized as emerging include: Augmentative and Alternative 
Communication Devices, Developmental Relationship-based Treatment, Exercise, Exposure 
Package, Functional Communication Training, Imitation-based Intervention, Initiation 
Training, Language Training (Production and Understanding), Massage Therapy, Multi-
component Package, Music Therapy, Picture Exchange Communication System, Reductive 
Package, Sign Instruction, Social Communication Intervention, Technology-based 
Intervention, and Theory of Mind Training. Interventions categorized as unestablished include: 
Animal-assisted Therapy, Auditory Integration Training, Concept Mapping, DIR/Floor Time, 
Facilitated Communication, Gluten-free/Casein-free diet, Movement-based Intervention, 
SENSE Theatre Intervention, Sensory Intervention Package, Shock Therapy, Social Behavioral 
Learning Strategy, Social Cognition Intervention, Social Thinking Intervention, and any other 
intervention that has no research or research on the topic is published exclusively in non-peer-
reviewed journals. 
Biomedical treatments. Biomedical treatments aim to treat biological causes of 
disorders. For autism, biomedical treatments include off-label prescribed medications (anti- 
infectives, immunoglobulins, chelation agents, digestive enzymes, oxytocin, secretin) and 
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other medical treatments (specialized diets, HBOT), stem cell transplantation, transcranial 
magnetic therapy, vagus nerve stimulation) with high potential for negative side effects and/or 
complications and high financial and time costs (Levy & Hyman, 2015). Off-label medications 
can be provided over the counter or by prescription but used for an unapproved indication, 
age, or dosage (Levy & Hyman, 2015). Natural products are available over the counter as an 
oral or topical preparation (e.g., dietary supplements, neutraceuticals), and their use is often 
guided by non-peer-reviewed sources (Levy & Hyman, 2015). Among biologically-based 
CAM options, only elimination diets (specifically gluten- and casein-free diets), omega 3, 
vitamin supplementation, and HBOT have been extensively studied (Brondino et al., 2015). 
Diets and supplements. Elimination diets, especially gluten- and casein-free diets, are 
some of the most popular CAM treatments used for autism (Brondino et al., 2015). Gluten- 
and casein-free diets have been advertised as intervention for core symptoms and comorbid 
gastrointestinal issues (Akins et al., 2010). The unproven “opioid excess” hypothesis of ASD 
is generally the cause for use of such diets, which supposedly decrease endogenous opioids in 
the brain that contribute to neurobehavioral symptoms. Another rationale is the supposed 
presence of specific food allergens that could enhance immune response in predisposed 
individuals (Brondino et al., 2015). Controlled studies of these diets for ASD have been 
limited, with only two small RCTs meeting review criteria in a 2008 Cochrane review 
(Millward, Ferriter, Calver, & Connell-Jones, 2008). At this time, elimination diets do not 
have evidence supporting their use for ASD (Brondino et al., 2015). Individual benefits may 
be due to subclinical intolerance to food allergens, which may be under-diagnosed or under-
treated in ASD due to impaired communication skills (Jyonouchi, 2010). Beyond being time-
consuming and expensive, such diets create additional limits on feeding behavior of children 
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who are frequently already selective about food. Nutritional deficiencies, potentially resulting 
in bone loss, are a possibility, although little research has been conducted on risks associated 
with such diets (Akins et al., 2010). 
The rationales for vitamin use as a treatment of ASD include dietary deficiencies of 
vitamins and micronutrients due to food selectivity or gastrointestinal issues (Brondino et al., 
2015). Studies of vitamins as a treatment option resulted in inconsistent findings, and more 
scientifically sound studies are warranted before conclusions can be drawn (Brondino et al., 
2015). One potential side effect of dietary supplements and administration of excessive multi- 
vitamins is vitamin toxicity (Akins et al., 2010). 
Chelation. The intended purpose of chelation is to remove heavy metals from the body, 
as in heavy metal poisoning. Removal of heavy metals is accomplished by injecting various 
chemical substances to bind and withdraw specific metals from the body (Risher & Amler, 
2005). The unproven theory to support chelation for autism is that some individuals with ASD 
have deficits in elimination of mercury and other heavy metals that affect immune and 
biochemical systems, and eliminating them results in neurocognitive recovery (T. N. Davis et 
al., 2013; Hertz-Picciotto et al., 2010). 
Concerns about elevated mercury levels due to exposure to thimerosol from vaccines 
have fueled these claims (Akins et al., 2010). In actuality, children ages 2 to 5 years with ASD 
have been shown to have similar mercury levels in their blood as their typically developing 
peers (Hertz- Picciotto et al., 2010). Unfortunately, chelation when used inappropriately (i.e., 
for anything other than heavy metal poisoning) has potential for various negative side effects 
(e.g., fever, vomiting, diarrhea, loss of appetite, hypertension, hypotension, cardiac 
arrhythmias, hypocalcemia), including death (Baxter & Krenzelok, 2008; Doja & Roberts, 
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2006). Due to the potential risks and the extremely limited quantity and quality of existing 
research, chelation is not supported as a treatment for ASD (T. N. Davis et al., 2013). 
Hyperbaric oxygen therapy. Hyperbaric oxygen therapy (HBOT) involves placement in 
a chamber in which the atmospheric pressure is compressed to a pressure greater than sea level, 
which increases the amount of oxygen in the blood (Gill & Bell, 2004). This treatment is 
generally used for carbon monoxide poisoning or air embolism (Brondino et al., 2015). In 
autism, HBOT reportedly targets potential dysfunction caused by hypoxia of brain cells, neuro-
inflammation, or deficient mitochondria (Halepoto, Al-Ayadhi, & Salam, 2014). Two studies 
published in 2006 and 2009 by the same research team reported improvement in ASD 
symptoms after HBOT (Rossignol & Rossignol, 2006; Rossignol et al., 2009). The Undersea 
and Hyperbaric Medical Society, a professional organization that maintains scientific rigor in 
hyperbaric medicine, investigated these claims. In the organization’s position paper, Bennett 
and Hart (2009) noted these studies presented numerous problems, the greatest of which was 
that the very low oxygen and pressures used in their treatment condition did not constitute 
HBOT, as the dosage could be delivered without compression (Akins et al., 2010). 
Thus far, the few methodologically sound studies on this topic do not provide sufficient 
evidence to support HBOT for the treatment of autism (Ghanizadeh, 2012; Halepoto et al., 
2014; Jepson et al., 2011). Furthermore, although HBOT appears to be safe, little attention has 
been paid to reporting adverse effects (Halepoto et al., 2014). Reported side effects include 
barotrauma, sinus squeeze, serous otitis, claustrophobia, reversible myopia, and new onset 
seizure (Halepoto et al., 2014).  
Secretin. Secretin, a gastrointestinal hormone, stimulates secretion of bile from the 
liver and acts as a stress regulatory hormone (Owley et al., 2001). A case series published in 
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1998 reported significant improvement in eye contact, alertness, and language following 
secretin administration for diagnostic gastrointestinal tests (Owley et al., 2001). Such 
anecdotal evidence of positive outcomes following single secretin injections helped spread its 
popularity (Bowker, D’Angelo, Hicks, & Wells, 2011). Nonetheless, no benefit over placebo 
has been found for secretin; media attention and the sensory experience of injections may 
have increased positive expectations (i.e., the placebo effect) for this treatment option 
(Sandler, 2005). Secretin as a treatment for autism has been thoroughly studied, resulting in 
lack of support for its use (Akins et al., 2010). 
Non-biomedical treatments. Non-biomedical treatments are those that target non- 
biological causes of disorders. For autism, the focus is on behavioral, emotional, and cognitive 
developmental deficits (Bodfish, 2004). This includes mind and body practices that generally 
are administered or taught by a trained practitioner and guided by non-peer-reviewed sources 
(Levy & Hyman, 2015). Given the general lack of side effects of non-biomedical treatments, 
these CAM options are considered by some families and professionals as more acceptable 
(Brondino  et al., 2015). Nonetheless, safe but not efficacious treatments redirect limited time 
and finances, at times resulting in strife and stress among families attempting to navigate 
challenging treatment decisions (Brondino et al., 2015). 
Massage. At present, massage is categorized as an emerging treatment for autism in 
the National Standards Project, Phase 2 (National Autism Center, 2015). Between 11 and 
16% of individuals with autism have reported using massage (Hanson et al., 2007). Massage 
is a means of manipulating soft tissues to affect both physiological (e.g., lowers blood 
pressure) and psychological states (e.g., improvement in mood) (Aourell, Skoog, & Carleson, 
2005; Ernst, 2009). There has been an increase in interest in massage as a treatment option for 
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ASD since the inclusion of sensory abnormalities in diagnostic criteria (Silva & Schalock, 
2013). 
Therapeutic touch is widely known for stress reduction, but there is some evidence to 
support its use to improve sensory impairment in children with ASD (Akins et al., 2010). For 
persons with ASD, touch may be aversive and result in abnormal responses (e.g., avoidance) 
(Silva & Schalock, 2013). Massage therapy aims to normalize tactile response in this 
population (Silva & Schalock, 2013). In one study of a massage therapy based on Chinese 
medicine, the authors reported improvement in tactile abnormalities, better child self-
regulation, and decreased parenting stress (Silva & Schalock, 2013). Nonetheless, limited 
evidence exists to support massage as a treatment of ASD symptoms, thus massage needs 
further study before becoming considered EBP (M. S. Lee, Lee, Park, & Shin, 2014). 
Acupuncture. Estimates of acupuncture use for ASD range widely, from 1 to 43% (M. 
S. Lee, Choi, Shin, & Ernst, 2012). Acupuncture is the application of needles or pressure to 
specific points on the body and is generally used to treat pain (Akins et al., 2010; Cheuk, 
Wong, & Chen, 2011). Side effects reported include crying due to fear or pain, irritability, 
bleeding, sleep disturbance, and increased hyperactivity (Cheuk et al., 2011). The current 
evidence base is fraught with issues, including high risk of bias, inconsistent and imprecise 
result reporting, and lack of heterogeneity in methodology (Cheuk et al., 2011). There are no 
published randomized studies supporting acupuncture as a treatment for ASD (Akins et al., 
2010). 
Chiropractic care. Chiropractic care includes manual manipulation of the body, 
particularly the spine, to correct alignment and subsequently relieve pain and improve 
functioning (Harvard Health, n.d.). The rationale for using chiropractic manipulation for 
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autism is unknown, and there are no published randomized studies that support its use for this 
purpose (Akins et al., 2010). Three case reports, one cohort study, and one randomized 
comparison trial have been conducted but did not provide positive results based on 
methodologically sound procedures (e.g., lack of control groups, small sample sizes; 
Alcantara, Alcantara, & Alcantara, 2011; Brondino et al., 2015). Published cases of serious 
adverse effects related to chiropractic treatment in the pediatric population are rare, although 
soreness, headaches, irritability, and other mild symptoms have been reported (Todd, Carroll, 
Robinson, & Mitchell, 2014). At this time, there is no support for chiropractic manipulation as 
a treatment for ASD. 
Music therapy. Of the non-biological interventions, music therapy has been studied 
most frequently and is sometimes considered part of behavioral intervention rather than a 
CAM treatment (Brondino et al., 2015). Music therapy involves developing relationships 
through music with aims to improve communication and expression (Geretsegger, Elefant, 
Mössler, & Gold, 2014). Music therapists, generally trained and credentialed professionals, use 
instruments and voices to engage participants in singing and movement activities to build skills 
in rhythm, listening, turn-taking, matching, and sharing (Sandberg & Spritz, 2012). Basis for 
its use includes reports that children with ASD respond better to music than spoken words 
(Sharda, Midha, Malik, Mukerji, & Singh, 2015). Although music therapy for ASD is 
considered safe, long-term effects remain unknown (Akins et al., 2010; Geretsegger et al., 
2014).  
According to a 2006 Cochrane review, music therapy for ASD was shown to be 
superior to placebo in terms of verbal and gestural communicative skills, but effects on 
behavior were not significant and of limited applicability to clinical practice (Gold, Wigram, & 
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Elefant, 2006). A more recent Cochrane review included 10 RCTs on music therapy, published 
between 1995 and 2012, that included a total of 93 participants (Geretsegger et al., 2014). 
Researchers suggested that music therapy may improve social interaction, verbal 
communication, social-emotional reciprocity, and nonverbal communication skills (Brondino 
et al., 2015). However, included studies had small sample sizes and were not consistent in 
terminology or methodology, making replication difficult. Music therapy may be promising in 
terms of changes in communication and social reciprocity, but further scientifically rigorous 
studies that allow for replication are needed. As such, music therapy is currently considered an 
emerging treatment for autism by the National Standards Project, Phase 2 (National Autism 
Center, 2015). 
Auditory integration training. In auditory integration training (AIT), an individual 
listens to music that has been modified, reportedly allowing the person to re-train their brain to  
eliminate hyper- or hyposensitivity to certain frequencies of sound (Brondino et al., 2015). In 
their review of auditory integration therapy and sound therapies for ASD, Sinha, Silove, 
Hayen, and Williams (2011) identified six RCTs involving a total of 182 individuals. Only two 
studies, both from the same research team, reported statistically significant improvements. The 
largest studies did not report significant differences between treatment and control groups or 
evidence for long-term benefits. Sufficient evidence to support AIT as treatment for ASD 
currently does not exist (Brondino et al., 2015). 
Sensory integration training. Sensory integration training (SIT) involves exposure to 
lights, sounds, smells, tastes, or textures, commonly introduced through play activities, that 
reportedly modulate how the brain responds to these modalities (Brondino et al., 2015). This 
goal is accomplished through the use of weighted vests, brushing or rubbing with instruments, 
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swinging, tactile pressure, and other similar techniques (Lang et al., 2012). Supporters of SIT 
for ASD suggest that sensory stimulation in the appropriate method and dosage may improve 
the sensory processing ability of nervous system (Lang et al., 2012). In their review of 25 
studies investigating SIT for ASD, Lang et al. (2012) found that only three of the studies 
suggested SIT was effective, and all three of these studies had significant methodological 
flaws. There is not sufficient evidence to support SIT as treatment for ASD (Brondino et al., 
2015). 
Medication 
At this time, there are no pharmacological treatments for the core symptoms of autism 
(Hsia et al., 2014; Weitlauf et al., 2014). In this population, psychotropic medication use may 
aim to increase focus, decrease hyperactivity, aggression, or irritability, and/or address co- 
occurring symptoms (e.g., anxiety, mood problems, tics; Mire et al., 2015). The only FDA- 
approved medications for ASD are risperidone (Risperdal) and aripiprazole (Abilify), which 
are indicated for treatment of irritability in 5 to 16 year olds (Hsia et al., 2014; Lofthouse, 
Hendren, Hurt, Arnold, & Butter, 2012). These drugs have demonstrated improvement in 
challenging behavior (e.g., emotional distress, aggression, hyperactivity, self-injury), but both 
have high incidence of harm (Weitlauf et al., 2014). 
Families report concerns about side effects and safety of prescription medication 
(Hanson et al., 2007). Nonetheless, between 30 and 70% of persons with ASD have received 
treatment in the form of medication (Frazier et al., 2011). In a recent study, Mire et al. (2015) 
found that 40% of families endorsed administration of psychotropic medication, with ADHD 
drugs (i.e., psychostimulants) as the most commonly prescribed. Further, endorsement of 
medication usage increased for older children. These authors suggested several potential 
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reasons for this trend: caregivers may be more comfortable with administering 
pharmaceuticals as children age, non- pharmaceutical treatment options have been exhausted 
without desired outcomes, treatment needs may have changed due to shifting symptoms, 
and/or caregivers have difficulty managing aggressive behaviors that may increase as children 
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Treatment Selection 
Internet surveys of caregivers of individuals with ASD have provided insight into 
treatment usage, perceived efficacy, and parental perceptions (Bowker et al., 2011). Thus far, 
most studies of treatment choices made by caregivers of individuals with ASD have focused 
on rates of use, whereas fewer studies of treatment selection assess influential factors that 
affect intervention decisions (Call, Delfs, Reavis, & Mevers, 2015). For both EBP and CAM, 
usage statistics vary widely, with hypothesized reasons including differing methods of 
obtaining rates (e.g., caregiver survey, review of records) and categorization (Christon et al., 
2010). Nevertheless, as studies of this nature continue, data can be aggregated into an eventual 
meaningful average. For now, varying estimates are available and are provided below. 
Rates of Use 
Number of treatments. Parents of children with ASD use an average of four to seven 
treatments at once (Bowker et al., 2011; Goin-Kochel, Myers, & Mackintosh, 2007; Green et 
al., 2006), and they have tried an average of seven to nine treatments total (Goin-Kochel et al., 
2007; Green et al., 2006). A more recent study of a small convenience sample indicated that 
caregivers used an average of 11.4 treatments but would use an average of 53.7 if there were 
fewer constraints (e.g., cost, availability) (Call et al., 2015). Number of treatments increases 
with symptom severity and presence of challenging behavior (Goin-Kochel et al., 2007; Green 
et al., 2006; Hanson et al., 2007). Use of numerous treatments at once means resources are 
spread more thinly instead of maximizing finances and time on options that are most likely to 
be efficacious (Call et al., 2015). Additionally, this strategy makes evaluating outcomes of a 
specific treatment selection difficult (Green et al., 2006). 
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Rates of EBP. Despite empirical support for ABA continuing to grow, only a little 
more than half of caregivers of children with ASD reported use of ABA-based therapies in an 
Internet survey conducted in 2006 (Green et al., 2006). Goin-Kochel et al. (2007) reported 
that 47.4% of parents reported current use of ABA for their 1.7 to 5.9 year olds, 31.9% of 
parents for their 6 to 11.9 year olds, and 23.3% for their 12 to 21.9 year olds. In the same 
survey, 60.5% of parents reported current use of early intervention for their 1.7 to 5.9 year 
olds, whereas an encouraging 87.7% of parents reported having ever used early intervention 
services for their 1.7 to 5.9 year olds. The statistics reported by Mire et al. (2015) are less 
encouraging with only 37.5% of families having endorsed ever using intensive behavioral 
intervention. The greatest proportion of usage was in 4-year-olds (24.4%) (Mire et al., 2015). 
Because social and communication skill deficits are a core symptom in autism, the high rates 
of use of social-focused interventions is not particularly surprising. For social skills training, 
current use was highest for adolescents (63%), with about 74% of parents reporting having 
ever tried social skills training for their adolescents (Goin-Kochel et al., 2007). For social 
stories, current use was highest for middle childhood (44%), with 59% of parents reporting 
having ever tried social stories for their 6 to 11.9 year olds (Goin-Kochel et al., 2007). 
Rates of CAM. CAM is used by individuals with ASD at higher rates than persons 
with chronic illnesses, genetic disorders, and cerebral palsy, with estimates ranging between 28 
and 95% (Akins et al., 2010; Christon et al., 2010; Levy, Mandell, Merhar, Ittenbach, & Pinto- 
Martin, 2003; Perrin et al., 2012). In a recent study, 47% of caregivers reported having used at 
least one type of CAM in the previous 6 months (Salomone, Charman, McConachie, & 
Warreyn, 2015). Unfortunately, Levy et al. (2003) found that 9% of their sample of children 
recently diagnosed with ASD were using potentially harmful treatments. To illustrate, 7 to 8% 
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of families reported using chelation for autism despite the associated risks (Green et al., 2006). 
A more recent study reported 2% of respondents endorsed use of any invasive, disproven, or 
potentially unsafe CAM (Salomone et al., 2015). 
Concurrent use of multiple CAM options is not uncommon (Levy & Hyman, 2015; 
Levy et al., 2003); in one study, for those parents who used any CAM approaches, the total 
number ranged from 1 to 12 with a mean of 2.15 approaches (Salomone et al., 2015). The most 
commonly used CAM treatments for ASD are natural products, special diets, and mind and 
body practices (Levy & Hyman, 2015). In the aforementioned study (Salomone et al., 2015), 
the most common CAM were diets and supplements (24% of sample reported use). This 
included use of vitamins by 15% of the sample and gluten- or casein-free diets by 13%. Next 
were mind and body practices with 23% of the sample having reported use, sensory integration 
therapy reported by 14%, and massage reported by 7%. Other unconventional approaches 
included pet therapy (14%) and homeopathy (10%). Similarly, in their sample of primarily 
Caucasian (87%) caregivers of higher SES (62% within $70-100 K family income), Hanson et 
al. (2007) found the most frequently reported CAM treatments were modified diets (38%; e.g., 
gluten-free, casein-free, wheat-free, sugar-free, dairy-free), vitamins/minerals (30%; primarily 
Vitamin B6), and food supplements (23%; e.g., omega 3 fatty acids, fish oil, DMG). These 
methods were followed by prayer/shaman, biofeedback, massage/body-work, herbal remedies, 
and chiropractic/osteopathic manipulation at 10-16% endorsement each. 
Influential Factors 
Sources of information. The rates of use statistics suggest the need for professionals 
in the field to better translate research findings to their practice and to put forth additional 
effort to transmit research findings to programs and families (Mire et al., 2015). Parents 
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necessitate continuously updated information about treatments and their efficacy from health 
care providers. Besides health practitioners, many families turn to other caregivers of children 
with ASD for this information because they share the difficult and confusing task of 
intervention choice and subsequent implementation (Goin-Kochel et al., 2007). 
In fact, H. H. Wong and Smith (2006) investigated frequency of sources of 
information about CAM, with results indicating family and community members endorsed as 
the most frequent source (35%). Physicians and the Internet were consulted about one fourth 
of the time (23% each), followed by other nonmedical professionals (4 to 27%) and books 
(15%) as less common sources. In a similar study, Miller, Schreck, Mulick, and Butter (2012) 
reported that 85.6% of their sample used recommendations from autism books, 85.4% from 
professionals other than medical doctors, and 75.2% from parents.  
In their survey, Deyro, Simon, and Guay (2014) found that a professional referral 
(e.g., pediatrician, other doctor, therapists) was the most influential source of information 
regarding treatment choices, with general media (e.g., Internet, television, newspaper) as the 
least influential source. The grouping of all professionals in this survey may be problematic, 
however. Therapists have varying degrees of experience and education. As such, some 
professionals are more likely to suggest evidence-based treatments than others. Indeed, in a 
study by Miller et al. (2012), the authors reported that psychologists and behavior analysts 
were the professionals most likely to endorse empirically based treatments, whereas medical 
and allied medical professionals were the least likely to do so. 
Although family members and friends, doctors, teachers, the media, and businesses all 
influence treatment choices made by caregivers of persons with autism (Schreck, 2014), the 
Internet is a first outlet for medical information for a majority of families (Levy & Hyman, 
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2015). This trend is worrisome given the current available information about autism 
treatments on the web. An online search for autism treatments yields accurate information 
interspersed with numerous sponsored advertisements for CAM options (e.g., chelation, 
HBOT [Schreck, 2014]). Blogs and other websites may be deceitful in their presentation of 
information, falsely making it seem as though certain unsupported interventions have 
empirical bases (Sandberg & Spritz, 2012). 
Additionally, the Internet is changing the experience of autism, and illness in general, 
for affected individuals and their families. Websites, bulletin boards, chat rooms, and social 
media sites have allowed Internet users to interact with others about ASD. There are certainly 
benefits to online support groups (e.g., increased understanding of ASD, identification of 
high-quality service providers), but these sources of information and interaction represent 
users with varying experiences and perspectives about autism (Conrad & Tan, 2014). Faulty 
science and misinformation can spread easily in such channels. Websites and groups 
promoting untested treatments introduce exposure to information about intervention with 
potentially harmful effects (Levy & Hyman, 2015). 
Further, advocacy and awareness websites vary in their discussion of evidence behind 
the information they present. For instance, some autism websites list interventions that have 
little empirical basis for use or are considered potentially harmful (Conrad & Tan, 2014). 
Without a source of accurate, data-supported information, caregivers hopeful for something 
that works can easily be led astray. In their examination of information provided by web sites 
of national autism associations, Stephenson et al. (2012) found that many presented positive 
descriptions and proponent claims for interventions that have been determined to be 
unsuccessful for ASD, with little reference to research. Further, some sites presented 
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conflicting descriptions and scientific evidence (e.g., one site presented negative science 
evidence but a neutral description for auditory integration), as well as providing links for 
interventions considered to have weak evidence and for which the site provided negative or no 
scientific support (Stephenson et al., 2012). With incompatible and inconsistent information 
provided by sites that may seem reputable to the untrained eye, intervention decision-making 
becomes even more difficult for caregivers to navigate. 
Child characteristics that influence choice. 
Autism severity. Based on extant research, severity of autism may affect treatment usage 
rates and selections. However, most studies have used diagnosis as a proxy for autism severity. 
Not only is this strategy less accurate than actual measures of severity, but also the diagnoses 
used are now obsolete given Diagnostic and Statistical Manual of Mental Disorders, 5th 
edition (DSM-5; American Psychiatric Association, 2014) criteria. Nonetheless, past research 
on this matter is discussed below. 
Autism type, described as “autism severity” in studies, has been shown to affect the 
number of treatments a child is currently using or has tried. Children with Autistic Disorder 
and Pervasive Developmental Disorder, Not Otherwise Specified (PDD-NOS) were currently 
using and had tried more treatments than their peers with Asperger’s Disorder (Goin-Kochel et 
al., 2007). Further, “autism severity” has been shown to influence use of EBP and CAM. 
Multiple studies have indicated that children and adolescents with a diagnosis of Autistic 
Disorder had higher rates of CAM use than peers with Asperger’s or PDD-NOS (Christon et 
al., 2010; Hanson et al., 2007; Perrin et al., 2012). To illustrate, CAM use was associated with 
more severe parent-reported diagnosis, with 90% of children with Autistic Disorder or PDD-
NOS and comorbid Intellectual Disability (ID)/Global Developmental Delay (GDD) were 
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reported to have used CAM (Hanson et al., 2007). Rates were lower for PDD-NOS without 
comorbid ID/GDD and Asperger’s Disorder or ASD-symptoms groups (69 and 42%, 
respectively) (Hanson et al., 2007). Hebert (2014) found that parents of children with a more 
severe diagnosis were more likely to consider biological interventions. Further, presence of 
comorbid symptoms, such as gastrointestinal issues, seizure disorder, and challenging 
behavior, increases likelihood of CAM use (Perrin et al., 2012). 
Unlike the majority of studies that have used autism diagnosis to measure symptom 
severity, Siller, Reyes, Hotez, Hutman, and Sigman (2013) used Autism Diagnostic 
Observation Schedule (ADOS; Lord, Rutter, DiLavore, & Risi, 2002) scores to look at social 
affect and restricted and repetitive behaviors. The authors reported that severity of symptoms 
did not independently predict children’s intervention programs. As such, there is a lack of 
consensus at this time about whether or not symptom severity affects treatment choice.  
Age. There have been minimal studies of changes in intervention use across the lifespan 
or of age as a factor in treatment decisions. One research group suggests that use of CAM is 
relatively stable across age span, perhaps because lack of research means these treatments are 
not specifically indicated for certain ages (Mire et al., 2015). Conversely, younger children 
have been shown to use more diet, behavioral, educational, or alternative treatments  than older 
children, whereas the opposite is true of psychotropic medication treatments (Goin- Kochel et 
al., 2007; Mire et al., 2015). This result may be due to the finding that puberty can cause 
additional challenging behavior not well managed using behavioral techniques (Goin-Kochel et 
al., 2007). Alternatively, this finding may reflect changing needs; caregivers may decrease the 
number and/or intensity of treatment options as core ASD symptoms improve over time (Mire 
et al., 2015). Overall, few studies have investigated age as a predictor of CAM or EBP use. 
	   34 
Caregiver characteristics that influence choice. 
Socioeconomic Status (SES). Caregivers of lower socioeconomic status (SES) may 
have difficulty locating or affording empirically based treatments. Poor access to treatment 
has been proposed as a reason caregivers implement CAM treatments for their children with 
ASD (Hanson et al., 2007). Additionally, cost of high intensity interventions (e.g., ABA) has 
been reported by parents as a reason these options are not used (Valentine, Rajkovic, Dinning, 
& Thompson, 2011). Interestingly, CAM usage also has been reported as more common 
among families with high SES (Brondino et al., 2015). At present, research is inconsistent 
regarding the effect of SES on EBP or CAM use. 
Nevertheless, treatments that are available through state programs and/or school 
settings (e.g., speech, occupational therapies) may be used more frequently due to their wider 
and free availability, regardless of family SES. In their sample, Mire et al. (2015) found that 
80.2% endorsed using school-based speech therapy (compared to 53.2% for private speech 
therapy), and 67.6% endorsed using school-based occupational therapy. Further, the mandate 
for autism services for Medicaid beneficiaries that was passed in 2014 may help remedy 
financial issues associated with autism treatments, potentially decreasing differences in 
treatment use based on SES (Mire et al., 2015). 
Education. As with SES, researchers have not reached a consensus regarding the effect 
of parental education on CAM vs. EBP use. In a study by Miller et al. (2012), the authors 
reported that neither education level nor college major significantly contributed to parental 
choice of ASD treatments. They concluded that parents from a variety of financial and 
educational backgrounds use CAM options. Similarly, researchers indicate that parents’ 
comprehension and conceptualization of illness differs significantly from biomedical evidence 
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regardless of parental education (Shyu, Tsai, & Tsai, 2010). In a study of parents of children 
with autism in Chinese culture, education level did not affect cause attribution or intervention 
choice. Rather, cause attribution, accessibility, and affordability all influenced the treatments 
parents selected (Shyu et al., 2010). 
In contrast to results suggesting that education does not play a part in selection, some 
researchers have found that level of education does make a difference. In Siller et al. (2013), 
the authors reported family characteristics as significant predictors of service utilization, 
including “indicators of SES,” which included annual household income and parental 
education. In several studies, parents with a high education level were found to be more likely 
to report use of CAM (e.g., diets, supplements) than parents with a lower education level 
(Hanson et al., 2007; Salomone et al., 2015). Salomone and colleagues (2015) have suggested 
this finding might be moderated by SES; for instance, mind and body practices cost on 
average twice the amount of self-care therapies such as supplements, which may be why they 
were used less in the lower SES group, which was indexed by education level. In contrast, 
Howard, Sparkman, Cohen, Green, and Stanislaw (2005) reported that parents of children 
enrolled in intensive behavior analytic intervention, an EBP, averaged one to two more years 
of education than the parents of children participating in intensive “eclectic” intervention or 
non-intensive public early intervention programs. At present, more research is needed to 
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Purpose 
The current study aimed to replicate surveys of caregiver treatment choices and 
expand on previous findings by incorporating a parent-report measure of autism symptom 
severity. In order to best effect change in caregiver choice, psychologists must know what 
factors influence families during this process. The author aimed to answer a variety of 
questions that could help clinicians and other providers guide families affected by ASD 
toward more evidence-based selections. As such, the current study aims to examine the 
sources of information, child characteristics, and caregiver characteristics that predict EBP 
versus CAM use. Results may help professionals target certain client populations for 
increased psychoeducation about the use of empirically-based treatments for autism. Future 
projects based on results may include online resources or pilot groups that could provide 
psychoeducation in an accessible format. Additionally, further effort could be made to educate health 
professionals who may be providing incorrect or outdated information.  
First, the author wanted to know what EBP and CAM treatments caregivers choose for 
their children and adolescents with ASD (Q1). Based on extant research regarding treatment 
selections, the author predicted that behavioral interventions would receive the greatest 
percentage of endorsement, likely by about half of caregivers. Further, the author suspected 
respondents would indicate use of multiple treatments, both CAM and EBP, at once. Finally, 
the author predicted relatively high rates of Speech Therapy, Occupational Therapy, and 
Physical Therapy across diverse respondents due to availability of such treatments through 
early intervention and school programs. 
Next, the author wanted to examine the most frequently consulted and most trusted 
sources of information about treatments for ASD (Q2a and Q2b). Consistent with extant 
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research, the author predicted that most common sources of information would be medical 
professionals, websites/online searches, and other caregivers of individuals with ASD. Further, 
the author hypothesized that CAM Hours and EBP Hours would vary based on the most trusted 
source of information. Caregivers who indicated their most trusted source of information was 
the Internet or other individuals caring for persons with ASD were predicted to endorse higher 
levels of CAM due to the prevalence of misleading and incorrect information present among 
these sources.  
Finally, the author wanted to determine what factors (i.e., information source, child 
characteristics, caregiver characteristics) predict hours of CAM versus hours of EBP (Q3). The 
author hypothesized that most trusted source of information, child age, child symptom severity 
of ASD, respondent education, and respondent income would all contribute to treatment hours. 
The author predicted that consulting healthcare providers, as opposed to non-healthcare 
providers (e.g., websites, social media, other caregivers), would result in greater use of EBP 
treatments. Based on prior research, the author anticipated that greater severity of ASD 
symptomatology would result in greater endorsement of CAM usage. Following extant data, the 
author hypothesized that younger children would engage in greater EBP hours (behavioral 
treatment in particular), and older children or adolescents would engage in less non-
pharmaceutical treatment overall. Further, the author suspected that higher respondent 
education and income would predict higher EBP Hours and lower CAM Hours. Caregivers with 
higher levels of education may be more likely to consult scientific evidence and base 
intervention decisions in part on empirical support, resulting in greater endorsement of EBP. 
Additionally, caregivers with higher incomes may have fewer financial barriers to obtaining 
treatment and may have better insurance coverage of empirically-based interventions. 
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Method 
Participants 
For the present study, data was collected between January 11, 2016 and May 1, 2016. 
Within these dates, 129 people completed the consent to participate page and began the survey. 
Of total respondents (N=129), 80 participants (62%) completed the survey in its entirety. 
Respondents who did not finish the survey were not excluded from analyses, as data was 
included as available. The software program that the survey authors used to run the survey 
allowed any individual with a link to the survey to complete it. As such, the author used 
responses to certain survey questions as inclusion and exclusion criteria for analyses.  
The author of the current study aims to examine treatment selections made by caregivers 
for children and adolescents. For this purpose, responses of caregivers were included if they 
indicated they are a biological or adoptive parent or primary guardian who provides the majority 
of care for an individual with ASD. Inclusion and exclusion criteria are enumerated following 
and represented visually in Figure 1. Respondent numbers are provided specifically for each 
statistical analysis. 
Among total respondents (N=129), ages of children (i.e., person with ASD) ranged from 
1 year 6 months to 32 years. For the current study, inclusion criterion #1 was age range of child 
between 1 year 0 months and 17 years 11 months. Only 90 participants answered the question 
regarding child age. Approximately 15 respondents stopped when they read this question (“How 
old is your child?”), which was the first question about the child. Based on responses regarding 
relationship to the individual with ASD (“What is your relationship to the individual with 
ASD?”), it seems these respondents may not have understood that only caregivers serving a 
parental role (i.e., parents, grandparents; not spouses, therapists) were intended to serve as 
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respondents. Of the 90, 19 responses were eliminated based on age outside of inclusion criteria; 
71 respondents remained.  
Next, inclusion criterion #2 was relationship to the child. Only those respondents serving 
a parental caregiver role were included. Of the 71 respondents included, 54 were biological 
mothers, 4 were biological fathers, 1 was an adoptive mother, 1 was an adoptive father, and 11 
indicated “other.” Most of the “other” category indicated that the respondent was the child’s 
grandparent. However, one “other” respondent was removed due to indicating s/he was the 
child’s therapist; 70 respondents remained.  
Next, inclusion criterion #3 was child’s diagnosis.  Only children with an ASD were 
included; as such, only respondents that indicated their child had Autistic Disorder, PDD-NOS, 
Asperger’s Disorder/Syndrome, Autism Spectrum Disorder, or “other” responses that fit into one 
of these categories was included. This criteria resulted in two further eliminations, for responses 
of “Sensory Processing Disorder” and “Not sure.” These overall inclusion criteria left a sample 
of 68 respondents remaining. Data of these 68 respondents is provided following.  
Measures 
Survey. The final version of the survey available on Qualtrics for participants to complete 
can be found in the Appendix (pg. 91). The survey included questions about demographics, 
treatment options with which the caregiver is familiar, treatment options which the individual has 
used and is currently using, sources of information about treatment options, influences on 
treatment decisions, etc. An additional measure was included with the original survey, as 
described below. Although this increased the survey length, gathering information about ASD 
symptom severity allowed for analysis of the influence of this factor on intervention selections. 
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Figure 1. Flowchart Representing Inclusion and Exclusion Process 
During preliminary development of the original survey, each treatment included (N=39)  
was asked about individually for endorsement of use. Preliminary survey completion testing by 
the authors concluded that this took too significant an amount of time and would be extremely 
burdensome for respondents. The authors predicted that keeping the survey in this original 
format would cause significant drop-out when the respondents reached this section (particularly 
given the lack of monetary incentive for participating).  The authors concluded that the survey 
would be more feasible for respondents if the treatments were grouped into categories, 
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decreasing the number of questions substantially. Treatments were separated into groups of 
either EBP or CAM interventions and presented in a random order. Categorization was based on 
loose themes (e.g., cognitive interventions, social skills interventions, vitamins/supplements and 
diets, harmful treatments).  
Autism Spectrum Disorder – Diagnostic, Child Version (ASD-DC). The ASD-DC 
(Matson & González, 2007) is a caregiver report measure of autism symptoms among  
individuals ages 2 to 16 years. It is a 40-item scale within the Autism Spectrum Disorder Battery, 
Child Version. Internal consistency of the measure is excellent at .99, and test-retest and inter- 
rater reliability are both good, at κω=. 77 and κω=. 67 respectively (Matson, Gonzales, Wilkins, 
& Rivet, 2008). Chronbach’s alpha for the present sample indicated a high degree of internal 
consistency (40 items, α = 0.94). Symptoms to be rated include those spanning domains of 
diagnostic criteria; there are questions regarding communication skills, social abilities, restricted 
interests, repetitive behavior, sensory issues, etc. Caregiver respondents rate the symptoms 
compared to the child’s peers as ever being a problem on a scale of 0 to 2, with 0 implying not 
different/no impairment, 1 implying somewhat different/mild impairment, and 2 implying very 
different/severe impairment. The purpose in including the ASD-DC was to obtain a caregiver 
report of autism symptom severity, thus the endorsements were summed for a total score.  
Procedure 
The authors of the survey received approval from the Louisiana State University 
Institutional Review Board prior to initiation of the study. The authors advertised the survey via 
posts on social media sites (e.g., Facebook, Twitter, NextDoor, MeetUp), via emails on listservs 
for a variety of groups (e.g., autism groups for each state), and via approved flyers posted in 
providers’ offices (e.g., LSU Psychological Services Center, The Emerge Center). Although 
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these sources spanned the country, the resulting sample was less demographically diverse than 
expected. Homogeneity of the sample may be due in part to the manner in which the survey was 
advertised and the format in which the data was collected (i.e., on the Internet), which is 
discussed in the Limitations section (pg. 76).  
The survey was created using Qualtrics Research Suite, provided by Louisiana State 
University. This program allows survey authors to send an anonymous link for completion. 
Additionally, we enabled the Anonymizing Responses feature, which removes data about which 
response came from which participant, including removing IP addresses from results. As such, 
all responses were anonymous. 
When potential participants clicked the link for the survey, they were directed to a 
webpage to complete an informed consent process. In the event that an individual reached the 
consent form and chose not to complete the informed consent process, the program sent them 
to the end of the survey, and they were not able to participate or access any survey questions. 
Once the caregiver completed informed consent, he or she was redirected to the first questions 
of the survey. The ASD-DC was included in full within the survey, between blocks of author-
created questions. The survey closed when the respondent pressed a button to indicate he or she 
had completed the survey. 
Statistical Analyses 
All statistical analyses were performed in SPSS 21. Demographics were calculated for 
the sample to provide an overview of the characteristics of the participants. Descriptive 
statistics were run for all variables. For the predictor variable of child symptom severity of 
ASD, the endorsements for each item of the ASD-DC were summed. For the primary outcome 
variables, respondents endorsed current use of a certain treatment group for their children with 
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ASD and subsequently provided number of hours per week of use for each treatment group. 
Endorsed hours for each respondent were then divided into CAM Hours and EBP Hours based 
on the categorization by the National Standards Project.  
For hours per week, values can be greater than the actual number of clock hours in a 
week. Each treatment group was considered on an individual basis, and multiple treatments 
could be used simultaneously (e.g., receiving 40 hours per week of ABA at the same time as 3 
hours of Social Stories and 3 hours of Picture Exchange). However, upon visual inspection of 
the data, it was noted that multiple caregivers (N=5, almost 10% of the sample who completed 
these questions) endorsed hours per week of CAM Group 3 (vitamins and supplements, special 
or restricted diets, and oxytocin) between 40 and 75 hours (i.e., the maximum number of hours 
permitted). The authors of the survey determined that this question was likely misinterpreted by 
respondents; specifying that hours endorsed should be time the child and/or family was 
involved in actual administration of treatment (e.g., purchasing ingredients and preparing 
specific diet; taking vitamins) would have been helpful in acquiring the data desired. The 
authors assume that caregivers endorsed the maximum number of hours because their children 
were receiving this type of treatment all hours of the day (e.g., constant adherence to 
specialized diet). It was clear that these hour values were not representative of hours involved in 
treatment and thus did not fulfill the purpose of these analyses. Due to the lack of validity of 
endorsements on this category, it was excluded from Total Hours, Hours of EBP, and Hours of 
CAM for all participants. These unrepresentative values altered the CAM data significantly; the 
mean hours of CAM per week was about 12 prior to removal of this value and about 8 after 
removal of the value. All other values were added for each participant to create a Total Hours 
value and separated by CAM and EBP for Hours CAM and Hours EBP values. 
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What EBP and CAM treatments do caregivers choose for their children and adolescents 
with ASD (Q1)? As discussed, treatments were grouped in order to decrease likelihood of 
respondent fatigue and subsequent discontinuation, resulting in an inability to pinpoint 
endorsements for particular treatments (e.g., could not determine percentage of respondents 
who endorsed use of ABA in particular). Additionally, number of treatments in current use 
could not be determined. Instead, current treatment selection results are presented in 
percentages and thus could still be compared with previous research on intervention choice. 
These percentages represent the proportion of the sample that uses each intervention. Percentages 
are compared within and between their categorization as either CAM or EBP interventions. 
What are the most frequently endorsed sources of information about treatments for 
ASD (Q2a)? What is the most trusted source of information about treatments for ASD (Q2b)? 
Similar to Q1, both endorsed sources of information and most trusted source of information 
results are presented in percentages. Further discussion is provided in the Results section 
regarding an error related to the results of Q2b.  
What factors (i.e., information source, child characteristics, caregiver characteristics) 
predict hours of CAM versus hours of EBP (Q3)? For this question, two separate independent 
samples t-tests and two separate multiple regression analyses were conducted. For each pair of 
analyses, either CAM Hours or EBP Hours was the dependent or outcome variable.  
First, the researcher wanted to examine information source. Due to an error in survey 
construction, respondents were able to pick more than one source to answer the question, “Of 
the sources of information about autism treatments you use, which is your most trusted 
source?” (formatted as in survey). Of the 59 respondents who completed this section of 
questions, 29 misinterpreted this question and chose multiple sources as “most trusted.” Due 
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to this limitation, information source was examined apart from the other potential predictors 
of CAM versus EBP use. The author assessed differences in CAM versus EBP use between 
the group of respondents that endorsed their most trusted source as a healthcare provider (e.g., 
doctors, psychologists, therapists) and the group of respondents that endorsed their most 
trusted source as a non-healthcare provider (e.g., other caregivers, media, teachers). 
 The independent samples t-test can be used to assess for statistically significant 
differences between means of independent groups on a continuous dependent variable (Laerd 
Statistics, 2015). Before the t-tests were run, assumptions for using independent sample t-tests 
were checked (i.e., testing for outliers, normality, homogeneity of variances). The data must 
meet these assumptions before analyses can take place; as such, transformations of the data 
were made as needed. If an independent samples t-test is statistically significant, the 
researcher can conclude that the means of the groups differ significantly. Effect sizes were 
calculated to provide a measure of the practical significance of the results whether the tests 
reached significance or not. Cohen’s d values can be interpreted as .2 as a small effect size, .5 
as a medium effect size, and .8 as a large effect size (Cohen, 1988).   
Multiple regression can be used to understand whether each independent variable 
added to the model is important in explaining the variance of the dependent variable (Lund & 
Lund, 2013). Before the multiple regression analyses were run, assumptions for using multiple 
regression were checked (i.e., independence of observations, linear relationship between 
dependent variable and each predictor and the dependent variable and the predictors 
collectively, homoscedasticity, multicollinearity, presence of significant outliers, residuals 
approximately normally distributed). The data must meet these assumptions before analyses 
can take place; as such, transformations of the data were made as needed. There is not yet 
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conclusive research regarding the separate influence of each predictor being analyzed in the 
present study and no comparisons of the contributions of these predictors together. As such, 
this analysis was considered exploratory, and all predictors were entered into the model at 
once.  
For these analyses, R2 was the first statistic to be examined. R2 represents the 
proportion of variation in the outcome variable explained by the predictor variables above and 
beyond the mean model. Adjusted R2 was reported as it corrects for positive bias present in 
R2, making it a more representative value expected in the population, and is also an estimate 
of effect size (Laerd Statistics, 2015). Next, statistical significance of the model was 
examined. If a model has a significance of p < .05, insertion of the predictors results in a 
model that is statistically significantly better at predicting the outcome variable than the mean 
model (Laerd Statistics, 2015).  Further, individual predictors were assessed using the t-
statistic, which tests the null hypothesis that the value of regression coefficients is significantly 
different from zero (Field, 2009). If the test is significant, the researcher can conclude the 
predictor variable significantly contributes to the prediction of the outcome. Subsequently, the 
regression coefficients for each predictor were examined for direction and considered in the 
context of the entire model. If the CAM and EBP models each had the same predictors significantly 
contributing to the outcome variable, the statistical test indicated by Paternoster, Brame, 
Mazerolle, and Piquero (1998) could have been employed to see if the coefficients were 
significantly different. If the coefficients differed significantly for a predictor, the researcher 
could conclude that the predictor was more or less important in predicting CAM or EBP hours. 
However, as discussed in the Results section, the predictors that reached significance were 
different for each of the models, thus this comparison was not indicated.  
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Results 
Respondent Demographics  
All percentages are rounded. Of the 68 respondents included in the overall sample, 59 
were Caucasian (87%), 3 were African American (4%), 2 were East Asian (3%), and 4 identified 
as “other” (i.e., Colombian/Italian, Caucasian/Hispanic, Hispanic/Asian, Eurasian; 6%). 
Caregiver respondents (N=68) were primarily female (N=62; 91%), with 6 respondents 
indicating they were male (9%). In terms of highest level of education completed (N=68), 2 
indicated they had completed some high school (3%); 2 were high school graduates (3%); 6 had 
technical, associate, or professional degree (9%); 11 had some college (16%); 24 were college 
graduates (35%); 2 had some graduate school (3%); and 21 had a graduate degree (31%).  In 
terms of annual household income (N=68), 6 indicated income less than $10k (9%); 4 indicated 
income between $10k and $25k (6%); 5 indicated income between $25k and $40k (7%); 8 
indicated income between $40k and $55k (12%); 7 indicated income between $55k and $70k 
(10%); 17 indicated income between $70k and $100k (25%); 13 indicated income over $100k 
(19%); and 8 indicated they preferred not to answer (12%). In terms of current marital status 
(N=68), 6 indicated they were single and had never been married (9%); 52 indicated they were 
married or in a long-term relationship (76%); 8 indicated they were separated or divorced (12%); 
and 2 indicated they were widowed (3%). In terms of location of respondents (N=67), 17 
different states were represented (Arizona, California, Colorado, Florida, Georgia, Idaho, 
Indiana, Iowa, Louisiana, Massachusetts, Michigan, Minnesota, Missouri, New York, North 
Carolina, Ohio, Pennsylvania, Rhode Island, South Carolina, Texas, Utah, Wisconsin). There 
were three states that represented more than 10% of respondents each: Louisiana (10%), Texas 
(10%), and South Carolina (24%). Most respondents (N=68) characterized the city/town where 
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they currently live as suburban (56%), followed by urban (34%), then rural (10%). The above 
statistics can be found in Table 1.  
Table 1. Respondent Demographics 





Caucasian 59 87 
AA 3 4 
East Asian 2 3 
Other 4 6 
Gender  N % 
  
  
Female 62 91 
Male 6 9 









Some HS 2 3 
Graduated HS 2 3 
Technical, Associate, Prof  6 9 
Some College 11 16 
Graduated College 24 35 
Some Graduate School 2 3 
Graduated Graduate School 21 31 
Prefer Not to Answer 0 0 









< 10 6 9 
10-25 4 6 
25-40 5 7 
40-55 8 12 
55-70 7 10 
70-100 17 25 
100+ 13 19 
Prefer Not to Answer 8 12 





Single/Never Married 6 9 
Married/Long-Term 52 76 
Separated/Divorced 8 12 
Widowed 2 3 
N=68 
    
Child Demographics 
All percentages are rounded. Of the 68 respondents, the children or adolescents for which 
respondents provided care were primarily Caucasian (78%), followed by a combination of 
ethnicities (15%); African American (4%); South Asian (2%); and East Asian (2%). In terms of 
gender (N=68), children were primarily male (82%). In terms of diagnosis (N=68), the most 
prevalent was ASD (66%); followed by PDD-NOS (16%); Autistic Disorder (12%); Asperger’s 
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Disorder/Syndrome (4%); and finally “other” (2%; High Functioning Autism). In terms of 
children’s current ages (N=68), age ranged from 18 months to 214 months (17.8 years), with a 
mean of 105.1 months (8.8 years) and a standard deviation of 45.86 months (3.8 years). In terms 
of children’s ages at diagnosis (N=66), age ranged from 12 months to 187 months (15.6 years), 
with a mean of 49.2 months (4.1 years) and a standard deviation of 33.5 months (2.8 years). In 
terms of children’s ages at initiation of treatment (N=59), age ranged from 7 months to 187 
months (15.6 years), with a mean of 44.6 (3.7 years) and a standard deviation of 32.7 months 
(2.7 years). In terms of children’s comorbid problems, 16% of respondents endorsed child’s 
diagnosis of intellectual disability; 22% endorsed child exhibits physical aggression; 24% 
endorsed child exhibits SIB; 54% endorsed child’s presence of sleep problems; and 6% endorsed 
child’s comorbid diagnosis of epilepsy or seizure disorder.  The above statistics can be found in 
Tables 2 and 3. 






South Asian 2 









Autistic D/O 12 
Asperger's 4 
HFA 2 
Age Mean (Years) SD (Years) 
Present 8.8 3.8 
Diagnosis^ 4.1 2.8 
Treatment 
Initiation^^ 3.7 2.7 
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Table 3. Child Comorbidity 
Comorbid Problems Endorsed by 
(%) 
Intellectual Disability 16 
Physical Aggression 22 
Self-Injurious Behavior 24 
Sleep Problems 54 
Epilepsy/Seizure Disorder 6 
 N=68 
Q1 
What EBP and CAM treatments do caregivers choose for their children and adolescents 
with ASD? From the sample of 68 respondents, 63 completed the current treatment questions and 
were eligible for inclusion in the Q1 analyses. Treatment groups are provided for reference in 
Table 4, and percentages of respondents who endorsed each treatment group are provided in 
Table 5. The treatment group endorsed by the greatest percentage of respondents overall was 
EBP Group 4 (74.6% of respondents), which included Language Training (Production) and 
Speech Therapy. The CAM treatment group endorsed by the greatest percentage of respondents 
was CAM Group 5 (66.1% of respondents), which included Occupational Therapy and Physical 
Therapy. The only treatment included in the current treatment questions that was not endorsed by 
any survey respondents was CAM Group 4, which included Chelation, HBOT, and Packing. 
Table 4. Treatment Groups 
Group Interventions Included 
EBP                 
1 EIBI 
2 ABA, Modeling, PRT, Natural Teaching Strategies 
3 Cognitive Behavioral Intervention, CBT 
4 Language Training (Production), Speech Therapy 
5 Parent Training, Peer Training Package, Self-Management Training, Schedules 
6 Scripting, Social Skills Package, Story-Based Intervention 
CAM                 
1 
Alternative Communication Devices, FCT, PECS, Sign Instruction, Facilitated Communication, Music 
Therapy, Animal-assisted Therapy, Floor Time, Play Therapy 
2 
Exercise, Massage Therapy/Deep Pressure, Auditory/Sensory Integration, Chiropractic, Art Therapy, 
Acupuncture 
3 Vitamins and Supplements, Special/Restricted Diets, Oxytocin 
4 Chelation, HBOT, Packing 
5 OT, PT 
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Table 5.  
Current Intervention Use 
Endorsed by Respondents 
















What are the most frequently endorsed sources of information about treatments for ASD 
(Q2a)? What is the most trusted source of information about treatments for ASD (Q2b)? From 
the sample of 68 respondents, 59 completed the source of information questions and were 
eligible for inclusion in the Q2 analyses. Websites were the most frequently endorsed source of 
information (79.7% of respondents), followed by caregivers of children with ASD (69.5%), 
doctors (57.6%), Internet groups (52.5%), and ABA therapists (50.8%). Least endorsed source of 
information was newspapers (6.8%) and TV (10.2%). “Other” sources were endorsed by 10.2% 
of respondents; write-ins of “other” sources included “PCIT (Parent Child Interaction Therapy) 
therapist,” “work colleagues,” “[Medicaid] service coordinator,” “behavioral therapy agency,” 
and “RBT (Registered Behavior Technician) training.” See Table 6 for complete list of sources 
included and their endorsements. 
Due to an error in survey construction, respondents were able to pick more than one 
source to answer the question, “Of the sources of information about autism treatments you use, 
which is your most trusted source?” (formatted as in survey). Of the 59 respondents who 
	   52 
Table 6. Information Sources 
Source Percentage 
Websites 79.7 
Caregiver of ASD 69.5 
Doctor 57.6 
Online Group 52.5 
ABA Therapist 50.8 




Support Group 22 
Magazines 18.6 
Caregiver of non-ASD 16.9 






completed this section of questions, 29 misinterpreted this question and chose multiple sources 
as “most trusted.” Table 7 includes percentages of most trusted source including all participants, 
including respondents who selected multiple sources as most trusted (e.g., one respondent wrote, 
“They are about equal.”).  Table 8 includes percentages of most trusted source including only the 
30 respondents who selected a single most trusted source, separated by healthcare provider and 
non-healthcare provider. The 30 respondents who answered as the authors intended were 
included in further analyses, as described in the Q3 section following. For this group, caregivers 
of children with ASD was the most frequently endorsed most trusted source of information 
(23.3%), followed by ABA therapists (16.7%). For the following analyses (Q3), most trusted 
sources were divided into two groups, healthcare providers and non-healthcare providers. Of 
these 30 respondents, 13 (43.4%) indicated their most trusted source was a healthcare provider, 
whereas 17 (56.7%) indicated their most trusted source was a non-healthcare provider.  
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Table 7. Most Trusted Source 
Source Percentage 
Caregiver of ASD 27.1 
Doctor 23.7 
ABA Therapist 23.7 
OT Therapist 15.3 
Books 11.9 
Online Group 8.5 
Teacher 8.5 
Psychologist 8.5 











What factors (i.e., sources of information, child characteristics, caregiver characteristics) predict 
hours of CAM versus hours of EBP? From the sample of 68 respondents, 50 respondents were 
eligible for inclusion in the following analyses of treatment hours. Respondents were removed if 
they did not complete the ASD-DC (N=4), if the children’s ages were outside of the range for 
which the ASD-DC is validated (i.e., 2 to 16 years; N=2), if they did not complete the current 
treatments section (N=1), and if they answered “Prefer not to answer” for respondent income 
(N=8). Further, one case was removed due to clear lack of understanding of the hour-selecting 
process (i.e., selected 40 hours for most interventions, including ones that cannot be used 
simultaneously), one case was removed due to endorsement that she does not use any therapy 
and works with her child without any formal training (i.e., endorsed 75 hours of “other”), and 
one case was removed due to complaint that she was “unsure how to respond” because she does 
everything herself via “homeschool” (N=3).  
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Table 8. Most Trusted Source by Group 




Caregiver of ASD 7 23.3 
    
Support Group 3 10 
Websites 2 6.7 
Online Group 2 6.7 
Books 2 6.7 
Teacher 1 3.3 
TV 0 0 
Newspaper 0 0 
Caregiver of non-
ASD 0 0 
Magazines 0 0 
Total 17 56.7 7 20.53 
    
  
    
Provider 
Source 
ABA Therapist 5 16.7 
OT Therapist 3 10 
Doctor 2 6.7 
Psychologist 2 6.7 
Other: PCIT 
Therapist 1 3.3 
PT Therapist 0 0 
Total 13 43.4 7.85 28.54 
N=30 
      
Results regarding sources of information were provided in the above section. In terms of 
total symptom endorsement (ASD-DC Total, summation of all endorsements) for the sample 
(N=50), the range was 59 to 118; mean score = 92.38; SD = 15.21. Both respondent income and 
respondent education were measured using scales. For both of these variables, the categorical 
coding actually represents continuous values. Respondent income and respondent education were 
entered as continuous variables in the following analyses (Carifio & Perla, 2008; Murray, 2013; 
Norman, 2010). For respondent income, 1 = less than $10k; 2 = $10k-$25k; 3 = $25k-$40k; 4 = 
$40k-$55k; 5 = $55k-$70k; 6 = $70k-$100k; 7 = more than $100k. For respondent education, 1 
= some high school; 2 = high school graduate; 3 = technical, associate’s, or professional degree; 
4 = some college; 5 = college graduate; 6 = some graduate school; 7 = graduate school graduate. 
In terms of respondent income for the sample (N=50), the range was less than $10k (coded as 1) 
to more than $100k (coded as 7); mean score = 5.02 ($55k-$70k coded as 5); SD = 1.85. In terms 
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of respondent education for the sample (N=50), the range was some high school (coded as 1) to 
graduate degree (coded as 7); mean score = 5.20 (college graduate coded as 5); SD = 1.67. 
Among the 50 eligible respondents, total hours per week of treatment ranged from 0 to 
122; mean = 31.94 hours; SD = 31.56 hours. Hours per week of CAM ranged from 0 to 75; mean 
= 8.7 hours; SD = 14.36 hours. Hours per week of EBP ranged from 0 to 119; mean = 23.24 
hours; SD = 24.82 hours. The treatment group with the highest average number of hours per 
week endorsed was EBP Group 2 (ABA, Modeling, PRT, Natural Teaching Strategies), mean = 
9.58 hours. The treatment group with the lowest number of hours per week endorsed was CAM 
Group 4 (Chelation, HBOT, Packing), mean = 0 hours. 
Although respondents endorsed a somewhat wide range of hours of treatment (i.e., 0 to 
122 total hours), the data was significantly skewed toward lower endorsements. For total hours, 
13 respondents (approximately 25% of the sample) endorsed fewer than 10 hours of overall 
treatment per week. For CAM hours, 39 respondents (78% of the sample) endorsed fewer than 
10 hours of CAM treatment per week. For EBP hours, 18 respondents (36% of the sample) 
endorsed fewer than 10 hours of EBP treatment per week. Histograms are provided in Figures 2 
and 3 that illustrate the overall patterns of fairly low rates of current treatment use and a few 
endorsements of high rates. 
Source of information analyses. 
The author intended to determine if most trusted information source groups differed in 
their use of CAM versus EBP treatments for ASD. As noted, information source was divided 
into two groups: healthcare provider and non-healthcare provider. First, a priori statistical 
analyses were conducted to determine if most trusted source groups differed significantly on 
demographic variables. Several Chi-square analyses were conducted. No significant difference of 
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respondent ethnicity between most trusted source groups was found, χ² (3) = 4.91, p = .18. No 
significant difference of respondent education was found, χ² (6) = 1.95, p = .93. No significant 
difference of respondent income was found, χ² (5) = 8.47, p = .13. As such, none of the above 
variables necessitated inclusion as covariates, allowing for the use of independent-samples t-
tests. 
Using G*Power (Faul, Erdfelder, Lang, & Buchner, 2007), an a priori power analysis was 
conducted to determine sample sizes required to achieve sufficient power. The standard in the 
behavioral sciences is to set the significance level at α=.05, which sets the power at .80 (Field, 2009; 
Hinkle, Wiersma, & Jurs, 2003). Accordingly, alpha was set to .05, power was set to .80, the effect 
size was set to .5 (medium), and there were two groups. With these settings, a total sample size 
of 102 was suggested. As noted prior, only 30 respondents selected a single most trusted source 
due to misinterpretation of the survey question. The statistical tests were conducted nonetheless, 
especially give the argument that such parametric tests are robust with respect to violations of 
sample size, normal distribution, and use of Likert scales (Norman, 2010).  
Two separate independent-samples t-tests were conducted to determine if there were 
differences in Hours CAM and Hours EBP between the group of respondents that endorsed their 
most trusted source as a healthcare provider (e.g., doctors, psychologists, therapists) and the 
group of respondents that endorsed their most trusted source as a non-healthcare provider (e.g., 
other caregivers, media, teachers). Results must be interpreted with caution given the small 
sample size and resulting power of .039. Future data collection may allow this analysis to be 
repeated with a larger sample size. 
According to numerical tests of normality (i.e., Shapiro-Wilk’s test), neither Hours CAM 
nor Hours EBP were normally distributed for both groups (health provider and non-health 
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provider as most trusted source). Plotted visually, both variables were positively skewed, with a 
significant number of responses of 0 hours per week of treatment (see Figures 2 and 3). A 
squareroot transformation was tested and did not increase normality substantially for either 
variable. Other transformations (i.e., log10, natural log, inverse) resulted in the elimination of 
any respondents who endorsed 0 hours of treatment per week. Although these transformations 
increased normality, eliminating these respondents limited interpretation and was thus not an 
option. As such, a cuberoot transformation was applied, which allowed inclusion of respondents 
who endorsed 0 hours but also allowed the data to approach normality. Thus, independent-
samples t-tests were conducted using transformed variables of Hours CAM and Hours EBP. 
Non-transformed means and standard deviations are provided following. 
Transformed Hours CAM was normally distributed for the provider and non-provider 
groups, as assessed by Shapiro-Wilk's test (p > .05). There was homogeneity of variances, as 
assessed by Levene's test for equality of variances (p = .66). Respondents who endorsed 
healthcare providers as their most trusted sources of information (N=13) averaged 7.85 hours of 
CAM. Respondents who endorsed non-healthcare providers as their most trusted source of 
information (N=17) averaged 7.00 hours of CAM. The groups did not differ significantly in 
terms of Hours CAM, t (28) = .52, p = .61, Cohen’s d = .19. Transformed Hours EBP was 
normally distributed for the provider and non-provider groups, as assessed by Shapiro-Wilk's test 
(p > .05). There was homogeneity of variances, as assessed by Levene's test for equality of 
variances (p = .55). Respondents who endorsed healthcare providers as their most trusted sources 
of information (N=13) averaged 28.54 hours of EBP. Respondents who endorsed non-healthcare 
providers as their most trusted source of information (N=17) averaged 20.53 hours of EBP.	  The 
groups did not differ significantly in terms of Hours EBP, t (28) = 1.08, p = .29, Cohen’s d = .40 
	   58 
 
Figure 2. Distribution of CAM Hours 
 
 
Figure 3. Distribution of EBP Hours 
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Regression analyses. 
Using G*Power (Faul et al., 2007), an a priori power analysis was conducted to determine 
sample sizes required to achieve sufficient power. As before, alpha was set to .05, power was set 
to .80, effect size was set to .25, and there were four predictors. With these settings, a total 
sample size of 53 was suggested. Similarly, Green (1991) suggested that number of participants 
should exceed the number of predictors by at least 50, which would necessitate at least 54 
participants for this study. As noted prior, 50 respondents met inclusion criteria for these 
analyses, which approaches the suggested sample size.  
Two separate multiple regression analyses were conducted to determine whether 
characteristics of the respondent (caregiver) and the child/adolescent predict hours of CAM 
treatment versus hours of EBP treatment differentially. Due to a lack of extant research 
comparing the included variables’ influences on use of evidence- and non-evidence-based 
treatment, all variables were entered at once as an exploratory analysis. Prior to running 
analyses, assumptions of multiple regression were checked, as explained in detail next.  
Hours of CAM was plotted to check visually for normality. This variable was 
significantly positively skewed, with a significant number of responses of 0 hours per week of 
CAM treatment (see Figure 2). A squareroot transformation was tested and did not increase 
normality substantially. Several other transformations (i.e., log10, natural log, inverse) resulted 
in the elimination of any respondents who endorsed 0 hours of CAM treatment per week. 
Although these transformations increased normality, eliminating these respondents limited 
interpretation and was thus not an option. Thus, a cuberoot transformation was applied, which 
allowed inclusion of the respondents who endorsed 0 hours but also allowed the data to approach 
normality. Based on plots of residuals, the independent variables collectively appear to be 
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linearly related to the transformed dependent variable (i.e., Hours CAM), and each independent 
variable (i.e., Child Age, ASD-DC Total, Respondent Income, Respondent Education) appeared 
to be linearly related to the transformed dependent variable (i.e., Hours CAM). Additionally, the 
plot of residuals suggested they are evenly spread over predicted values of the dependent 
variable, thus the assumption of homoscedasticity was not violated. None of the independent 
variables were strongly correlated with each other; the greatest correlation between independent 
variables was between respondent education and respondent income, with a correlation of 
r=.642, which is less than the suggested problematic correlation of r=.7 (Dewberry, 2004); Laerd 
Statistics, 2015). Additionally, collinearity statistics suggested no presence of problems with 
multicollinearity (i.e., all Tolerance statistics were greater than .1). There were no problematic 
outliers, leverage points, or highly influential points. 
Hours of EBP was plotted to check visually for normality. This variable was significantly 
positively skewed, with a significant number of responses of 0 hours per week of EBP treatment 
(see Figure 3). A squareroot transformation was tested and did not increase normality 
substantially. Several other transformations (i.e., log10, natural log, inverse) resulted in the 
elimination of any respondents who endorsed 0 hours of EBP treatment per week. Although 
these transformations increased normality, eliminating these respondents limited interpretation 
and was thus not an option. Thus, a cuberoot transformation was applied, which allowed 
inclusion of the respondents who endorsed 0 hours but also allowed the data to approach 
normality. Based on plots of residuals, the independent variables collectively appear to be 
linearly related to the transformed dependent variable (i.e., Hours EBP), and each independent 
variable (i.e., Child Age, ASD-DC Total, Respondent Income, Respondent Education) appeared 
to be linearly related to the transformed dependent variable (i.e., Hours EBP). Additionally, the 
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plot of residuals suggested they are evenly spread over predicted values of the dependent 
variable, thus the assumption of homoscedasticity was not violated. None of the independent 
variables were strongly correlated with each other (i.e., greatest correlation between independent 
variables was between respondent education and respondent income, with a correlation of 
r=.642, which is less than the suggested problematic correlation of r=.7 (Dewberry, 2004); Laerd 
Statistics, 2015). Additionally, collinearity statistics suggested no presence of problems with 
multicollinearity (i.e., all Tolerance statistics were greater than .1). There were no problematic 
outliers, leverage points, or highly influential points. 
A multiple regression was run to predict hours per week of CAM intervention from child 
age, child symptom severity of autism (as measured by total score on ASD-DC), respondent 
income, and respondent education. Child age, child symptom severity of autism, respondent 
income, and respondent education statistically significantly predicted hours per week of CAM, 
F(4,45)=3.40, p < .05, adj. R2 = .16. This result indicates that the model accounts for statistically 
significantly more variance in the outcome variable (i.e., Hours CAM) than would be expected 
by chance. Based on the adjusted R2, the model accounts for 16% of variance. Only one variable, 
respondent education, added statistically significantly to the prediction, p < .05. This result 
indicates that only respondent education is related to Hours CAM after controlling for all of the 
other predictors in the model, whereas child age, child severity of autism, and respondent income 
did not contribute significantly to the model. As seen in Table 9, respondent education had a 
significant negative regression coefficient (b = -.32), indicating respondents with higher levels of 
education had fewer Hours CAM (cuberoot transformed) after controlling for the other variables 
in the model.  
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Table 9. Regression Results for Hours CAM 
    Multiple Regression Weights 
Variable Mean^ SD^ Correlation with 
Hours CAM 
b  β 
Hours CAM 8.7 14.36    
Child Age (mo) 99.24 42.31 -0.165 -0.006 -0.233 
Child Severity of ASD 92.38 15.21 0.194 0.015 0.216 
Respondent Income 5.02 1.85 -0.199 0.115 0.208 
Respondent Education 5.20 1.67 -0.374** -0.317** -0.516 
^untransformed values   
* p <.05    ** p <.01   *** p < .001 
 
A multiple regression was run to predict hours per week of EBP intervention from child 
age, child symptom severity of autism (as measured by total score on ASD-DC), respondent 
income, and respondent education. Child age, child symptom severity of autism, respondent 
income, and respondent education statistically significantly predict hours per week of EBP, 
F(4,45)=2.62, p < .05, adj. R2 = .12. This result indicates that the model accounts for statistically 
significantly more variance in the outcome variable (i.e., Hours EBP) than would be expected by 
chance. Based on the adjusted R2, the model accounts for 12% of variance. Only one variable, 
child symptom severity of ASD (as measured by total score on ASD-DC), added statistically 
significantly to the prediction, p < .05. This result indicates that only child symptom severity of 
ASD was related to Hours EBP after controlling for all of the other predictors in the model, 
whereas child age, respondent income, and respondent education did not contribute significantly 
to the model. As seen in Table 10, child symptom severity of ASD had a significant positive 
regression coefficient (b = .024), indicating respondents with higher scores on the ASD-DC 
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Table 10. Regression Results for Hours EBP 
  Multiple Regression Weights 
Variable Mean^ SD^ Correlation 
with Hours EBP 
b  β 
Hours EBP 23.24 24.82       
Child Age (mo) 99.24 42.31 -0.194 -0.004 -0.133 
Child Severity of ASD 92.38 15.21 0.340** 0.024* 0.313 
Respondent Income 5.02 1.85 -.241 -0.161 -0.254 
Respondent Education 5.20 1.67 -.040* 0.084 0.119 
^untransformed values   
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Discussion 
The sample was fairly homogenous in terms of respondent demographics, particularly 
for ethnicity (Caucasian) and gender (female). Many of the respondents indicated they had a 
college or graduate degree, and the greatest percentage of respondents indicated they had an 
annual household income between $70k and $100k. Further, the majority of the sample 
indicated they were married. Thus, the survey respondents can primarily be characterized as 
well-educated, middle to upper-middle class, married, Caucasian, and female. Discussion of 
the limitation in diversity of the sample is discussed following (Limitations section, pg. 76).  
For the child characteristics, again the majority was Caucasian, but they were primarily 
male (82%). This finding was expected given the majority of individuals with ASD are male 
(i.e., approximately 4 to 1 male to female ratio; Fombonne, 2002). Mean age at the time of 
respondent survey completion was 8.8 years, whereas mean age at diagnosis was 4.1 years, 
and mean age at treatment initiation was 3.7 years. The finding that age at treatment initiation 
was earlier than age at diagnosis is somewhat surprising but may be accounted for by initiation 
of early intervention services (e.g., Speech Therapy, Occupational Therapy, Physical Therapy) 
for developmental delay (e.g., language delay, motor delay) before recognition of ASD 
symptoms and/or official diagnosis of ASD.  
In terms of comorbid problems, the most endorsed problem was sleep problems (54%), 
which is consistent with ranges of 40 to 80% suggested in previous research (Cortesi, 
Giannotti, Ivanenko, & Johnson, 2010). SIB and physical aggression were the next highest 
endorsed (24% and 22%, respectively). These rates were relatively low compared to previous 
research findings that suggest that up to 94% of children with ASD exhibit at least one 
challenging behavior (Matson, Wilkins, & Macken, 2008; Jang, Dixon, Tarbox, & 
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Granpeesheh, 2011). In this sample, only 16% of respondents indicated that their child with 
ASD had comorbid ID. Previous research suggests substantially higher rates, 50 to 70% 
according to a review on the topic (Matson & Shoemaker, 2009). Least endorsed among this 
sample was comorbid epilepsy/seizure disorder (6%). According to a review on the 
comorbidity of ASD and epilepsy, the present rate falls into the range of estimated prevalence 
from 5 to 38% (Tuchman & Rapin, 2002). Thus, rates of sleep problems and epilepsy were 
within previously reported ranges, but rates of challenging behavior and ID are significantly 
lower. One proposed explanation could be that the sample is less severe than average in terms 
of ASD symptomatology, which could potentially account for lower levels of challenging 
behavior and comorbid ID. However, ratings on the ASD-DC for this sample suggest that this 
was not the case, with even the lowest total score among the sample falling within the 
“Autistic Disorder” range (Matson & González, 2007). These statistics add to the research on 
the prevalence of these topics and may be used in future analyses, discussed following. 
Q1 
Based on extant research regarding treatment selections, the author predicted that 
behavioral interventions would be endorsed by about half of caregivers. For the current study, 
this would encompass EBP Groups 1 and 2 (i.e., EIBI, ABA, Modeling, PRT, Natural Teaching 
Strategies). Of the respondents who met inclusion criteria for this section of analyses (N=63), 
18.6% endorsed current use of Group 1 (i.e., EIBI), and 57.6% endorsed current use of Group 2. 
The latter result is fairly consistent with extant research suggesting behavioral intervention use 
among 40 to 50% of samples of children and adolescents with ASD (Green et al., 2006). 
Further, the author anticipated that the majority of caregivers would report using 
numerous treatments, both empirically based and not, simultaneously. This pattern was evident 
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given the high percentages of endorsements of treatments but could not be quantified 
specifically due to the need to group interventions. Further information regarding this 
hypothesis is provided in the treatment hours discussion.  
As noted, EBP Group 4, which included Language Training (Production) and Speech 
Therapy, was the most highly endorsed. High rates of these types of intervention were 
expected given availability of Speech Therapy through early intervention programs and 
subsequently through school districts. Further, high rates of endorsement for EBP Groups 5 
(i.e., Parent Training, Peer Training Package, Self-Management Training, Schedules) and 6 
(i.e., Scripting, Social Skills Package, Story-Based Intervention) are not surprising given that 
interventions such as Schedules and Story-Based Intervention (e.g., Social Stories) can easily 
be implemented at home by caregivers or at school by teachers with simple and/or one-time 
training from a professional (e.g., therapist, psychologist). The least endorsed EBP Groups 
were Groups 1 (i.e., EIBI) and 3 (i.e., Cognitive Behavioral Intervention, CBT). Lower rates 
of EIBI may have been due to child ages; the mean age for the sample was 8.8 years, which is 
above the target age for EIBI (Dawson, 2008). The lower endorsement for CBT interventions 
may be because this intervention is less widely known despite being considered EBP for ASD, 
there are fewer quality practitioners, and/or this is most relevant for individuals with comorbid 
mood or anxiety problems (Wood et al., 2009).  
In terms of CAM Groups, the most highly endorsed was Group 5, which included 
Occupational Therapy and Physical Therapy. Much like Speech Therapy, these are treatment 
options that are commonly provided in early intervention programs and subsequently by 
public school districts. Thus, they are much more easily obtained than other treatment options. 
The next most highly endorsed of CAM treatments were Group 1 (44.8%), Group 3 (35.6%), 
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and Group 2 (28.8%). Group 1 included a number of communication systems that may be used 
in other types of therapy (e.g., Alternative Communication Devices, PECS, Sign Instruction), 
including incorporation within EBP (e.g., use of picture exchange within an ABA center). 
Group 3 included Vitamins/Supplements, Special/Restricted Diets, and Oxytocin. 
Unfortunately, there is much misleading information being spread about special or restricted 
diets in particular, including at autism conferences for parents, in books, on websites, and in 
online support groups (Christison & Ivany, 2006). The abundance of misleading or simply 
incorrect information available likely drives the popularity of this particular option. Group 2 
included several mind-body practices (e.g., Exercise, Massage Therapy), which may prove to 
be reinforcing and/or beneficial in other ways, have ultimately not been found to have any 
effect on decreasing symptoms of ASD. The mind-body practices likely take little effort and 
cost to implement, making them an attractive option.  
Group 4, which encompassed harmful treatments including Chelation, HBOT, and 
Packing, was not endorsed as in current use by any respondents. Lack of current use among 
this sample was surprising given other reported rates of use of potentially harmful treatments 
between 2 and 9% (Green et al., 2006; Levy, Mandell, Merhar, Ittenbach, & Pinto-Martin, 
2003; Salomone, Charman, McConachie, & Warreyn, 2015). Of note, reported rates by these 
studies were observed to decrease over time, with the lowest endorsements in the most recent 
study. The current findings follow the same pattern as more recent studies, such as Salomone 
et al. (2015), which suggests that there is minimal current use of these potentially harmful 
treatments.  
Although many respondents endorsed current use of CAM treatments other than Group 
4, they are not currently using treatments that have been found to be dangerous or potentially 
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harmful in some way. Should psychologists or other healthcare providers discourage parents 
from CAM use if it is not potentially harmful? Some researchers argue that unsupported 
treatments should be tolerated but with close monitoring of results (Akins, Angkustsiri, & 
Hansen, 2010). In contrast, the author suggests that use of CAM treatments that are not 
dangerous may still be problematic in that they siphon off resources, particularly in terms of 
finances and time, from EBP that is more likely to benefit the child or adolescent with ASD. 
In clinical practice, caregivers may or may not be open to receiving information or suggestions 
regarding other treatments their children are receiving. If good rapport and a level of trust are 
established between the clinician and the family, encouraging families to devote resources to 
EBP rather than CAM treatments could be helpful. In these cases, the clinician must be 
committed to remaining current on the research on this topic to provide the most up-to-date 
information to families.  
Q2 
In the present study, the survey inquired more specifically than previous research about 
types of professionals that may be providing information to caregivers regarding treatment 
choices: doctor, psychologist, teacher, therapist (specified by type, including occupational, 
physical, speech, ABA), etc. The author predicted that medical professionals, websites/online 
searches, and other caregivers of individuals with ASD would be among the most endorsed 
sources of information. As predicted, the top three most endorsed sources of information were 
websites, other caregivers of children with ASD, and doctors. Following closely behind 
doctors were Internet groups (52.5%), ABA therapists (50.8%), OT therapists (49.2%), and 
books (45.8%). Psychologists ranked ninth out of 16 options, endorsed by 23.7% of 
respondents as a source of information. Given the previous discussion of misleading 
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information available online (both within websites falsely claiming to be evidence-based and 
within online social media groups), the finding that almost 80% of respondents use websites 
raises concern. 
 Although there are websites that have information on EBP, these are not the vast 
majority, and content on EBP may be interspersed with that on CAM, making information-
gathering even more difficult. The authors did not request that the respondents specify 
websites or online groups, although this may be helpful in the future to pinpoint misleading or 
reliable sources on the Internet. However, the ability to change poor sources of information is 
minimal. Thus, given the wide usage of the Internet as a source of information for parents 
navigating ASD treatment selection, there is a need for a reliable, evidence-based, up-to-date 
online source that can be easily comprehended by non-professionals. Should such a resource 
exist, a nationwide effort could be made to have healthcare providers, teachers, and other in-
person sources of information distribute the resource website address to the caregivers of 
children recently diagnosed with ASD.  
In terms of most trusted source, as discussed previously, 59 respondents answered this 
question, but 30 chose a single most trusted source. Both samples were represented in tables 
(Table 7 and Table 8). Among the larger group, of whom 29 selected more than one most 
trusted source, caregiver of ASD was the most common endorsement, followed by doctor and 
ABA therapist. Among the smaller group, caregiver of ASD remained the most common 
endorsement, followed by ABA therapist, and support group and OT therapist (10% each). 
Further, when the sources were divided between healthcare provider and non-healthcare 
provider sources, results indicated that more than half of respondents selected a non-healthcare 
provider as their most trusted source (56.7%). Most of these selections (40%) were sources 
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that were composed of caregivers of children with ASD (i.e., caregivers themselves, support 
groups, online groups). 
Why would respondents choose another caregiver of a child or adolescent with ASD as 
their most trusted source of information regarding treatment selection? Goin-Kochel, Myers, 
and Mackintosh (2007) have suggested that caregivers ask other parents of children with ASD 
because they have experienced a similar journey of selecting and implementing treatments for 
ASD.  However, an additional facet to consider, discussed in depth in Chivers, Yochim, and 
Silva (2013), is the subgroup of caregivers who mistrust professionals and experts, then spread 
their rhetoric and conspiracy theories through easily accessible channels online. These 
researchers discuss how there is a movement in the autism field, in part attributable to Jenny 
McCarthy, of caregivers who argue that their voices have been ignored by “big business.” 
Such caregivers may posit conspiracy theories about causes of autism and talk about their 
mistrust of the “evidence” provided by government health agencies. Members of this subgroup 
may argue that they will not take advice, even from professionals, that is in opposition to their 
parental intuition. Thus, such individuals primarily gather information from other caregivers, 
spreading misinformation exponentially on blogs, on social media, and in online support 
groups.  
Although having a group with whom to share this journey is useful for emotional 
support, caregivers should be cautioned that information gathered through such avenues 
represents varying opinions and reference to empirical evidence. Further, given the 
heterogeneous nature of presentation of ASD, what works anecdotally for one child with ASD 
is not necessarily going to prove successful for another. Thus, healthcare providers who have 
knowledge of the empirical bases of supported treatments, which have proven effective for 
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large samples of children, can guide the family to options that have evidence to support their 
use among individuals with ASD. 
Q3  
As noted in the Results section, many respondents endorsed relatively low levels of 
current treatment use. The data indicating what percentage of the sample received fewer than 10 
hours of treatment per week in each category was included to help illustrate this pattern. The use 
of 10 hours was an arbitrary number and is not intended to indicate the importance of 10 hours 
(or any certain number of hours) as an ideal treatment dose. The endorsement of fewer than 10 
hours of CAM by slightly more than 3/4 of the sample can be perceived as a positive trend. 
However, the endorsement of fewer than 10 hours of EBP by slightly more than 1/3 of the 
sample is somewhat worrisome because studies delivering low-intensity behavioral interventions 
have not resulted in the substantial gains that more intensive behavioral options have (Weitlauf et 
al., 2014). For instance, in their study of children receiving either behavioral treatment or eclectic 
treatment for an average of 12 hours per week, Eldevik, Eikeseth, Jahr, and Smith (2006) found 
that the behavioral treatment group made only modestly greater gains that may not have been 
clinically significant. Thus, it may be valid to argue that these low levels of EBP endorsed by 
respondents may not be significantly more beneficial than similar amounts of certain emerging 
treatments. As a result, psychoeducation regarding treatment should include discussion about 
intensity. Unfortunately, there are likely additional barriers to receiving this more intensive EBP 
treatment beyond what caregivers typically face acquiring intervention services.  
The author hypothesized that there would be differences in CAM and EBP use based 
on most trusted source of information. Sources were divided into healthcare providers and 
non-healthcare providers, with the specific hypothesis that those respondents who endorsed a 
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healthcare provider as their most trusted source would endorse greater hours of EBP 
interventions and fewer hours of CAM interventions than their counterparts who endorsed a 
non-healthcare provider as their most trusted source. Caregivers who endorsed non-healthcare 
providers, such as the Internet or other individuals caring for persons with ASD, as their main 
sources of information were predicted to endorse higher levels of CAM due to the prevalence 
of misleading and incorrect information present among these sources. 
Due to a small sample size (N=30), the author was unable to analyze this relationship 
with confidence. The under-powered independent-sample t-tests that were run indicated there 
was not a significant difference between groups in terms of mean CAM Hours or EBP Hours. 
However, examining the means on their own reveals interesting patterns that may have 
reached significance if the sample size had been larger. Contrary to the author’s hypothesis, 
mean CAM Hours was actually greater for the healthcare provider source group (mean = 7.85 
hours) than the non-healthcare provider source group (mean = 7.0 hours), with a small effect 
size. As expected, EBP Hours were greater for the healthcare provider source group (mean = 
28.54 hours) than the non-healthcare provider source group (mean = 20.53), with a small to 
medium effect size.  
Despite the lack of valid statistical analyses, the finding that CAM Hours endorsed by 
the healthcare provider source group were even marginally greater than the non-healthcare 
provider source group is somewhat surprising. Perhaps having a healthcare provider as a most 
trusted information source makes treatment-seeking in general, whether CAM or EBP, more 
likely. Those respondents who felt comfortable seeking information from a healthcare 
provider may also feel more comfortable with the process of obtaining intervention for their 
child (i.e., navigating a healthcare system), whether the treatment is evidence-based or not.  
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Health professionals presumably encourage consideration of research, but depth of 
knowledge of current empirical support may vary by field. For instance, Miller, Schreck, 
Mulick, and Butter (2012) found that psychologists and behavior analysts were more likely to 
recommend EBP than were medical or allied health professionals. Although healthcare 
providers (e.g., pediatricians) may have years of training and expertise, they still may not be 
providing to families the most accurate or up to date information regarding interventions for 
ASD. Healthcare providers who work primarily with persons with ASD, engage in research, 
and/or attend professional conferences or other learning events may better maintain an updated 
knowledge base regarding most recent evidence. Thus, these professionals are more likely to 
provide accurate information that would lead to engagement in EBP.  
Further, the grouping of sources into healthcare providers and non-healthcare providers 
may have been problematic in that some of the healthcare providers are those that provide 
treatment that are evidence based but not for ASD (i.e., OT and PT therapists). Thus, although 
these providers could be more scientifically-minded due to their training experience and the 
nature of their profession, they may encourage use of their services by persons with ASD. 
Encouraging use of their services would not be problematic so long as these therapists 
conceptualize their services as not treating ASD symptoms but rather as treating persons with 
ASD who have co-occurring deficits (e.g., motor) that the therapists can target given their 
expertise. If the sample size had been greater, analyses may have permitted further separation 
of information sources, which may have revealed more meaningful findings.  
Regarding the regression analyses, the author hypothesized that each of the predictors 
(child age, child symptom severity of ASD, respondent education, respondent income) would 
contribute significantly to the models. Although this analysis was exploratory in nature due to a 
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lack of research on comparisons of these specific predictors, the author had hypotheses for 
individual predictors that were added to the model. The author suspected that higher respondent 
education and income would predict higher EBP Hours and lower CAM Hours. The author’s 
theory was that caregivers with higher levels of education may be more likely to consult 
scientific evidence and base intervention decisions in part on empirical support, resulting in 
greater endorsement of EBP. Further, the author suspected that caregivers with higher incomes 
may have fewer financial barriers to obtaining treatment of any type and may have better 
insurance coverage of supported interventions. 
Additionally, the author predicted that child symptom severity of ASD would predict 
higher CAM Hours and that greater child age would predict fewer EBP Hours and CAM Hours 
due to greater medication use as a main intervention. Research on child characteristics that 
influence treatment choice has indicated that age and “severity” of autism diagnosis 
significantly influence number and type of interventions used in the past and currently in use. 
Specifically, more “severe” autism diagnosis (e.g., PDD-NOS versus Autistic Disorder) has 
been associated with greater CAM use. Further, research has suggested that medication use 
increases as persons with ASD age for a variety of reasons, including exhaustion of non-
pharmaceutical options and shifting treatment needs. 
In the first regression analysis, CAM Hours was the outcome variable. Results showed 
the model with predictors of child age, child severity of ASD (based on ASD-DC total score), 
respondent income, and respondent education statistically significantly predicted CAM Hours, 
although the model accounted for only 16% of variance. More notable was the result that only 
respondent education contributed to the model in a statistically significant way.  
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As predicted, higher respondent education predicted lower CAM hours, as evinced by 
the negative regression coefficient. However, there was no significant contribution by 
respondent income as was hypothesized, despite these variables being related (r=.642). This 
pattern of findings indicates that, when education is controlled within the model, income does 
not influence engagement in CAM treatments. The interpretation of these findings suggests that 
educated caregivers are less likely to use CAM treatments regardless of whether they have the 
resources. Why might this be the case? The author proposes that there may be various 
explanations: more highly educated individuals may be more likely to understand the 
importance of scientific inquiry and of an empirical basis for intervention use; such individuals 
may be more easily able to distinguish between valid and misleading information (e.g., on 
websites); and such individuals may have better knowledge of how and where to locate and 
implement evidence-based interventions, making use of EBP more likely than use of CAM.  
Pickard and Ingersoll (2015) reported that lower SES parents more frequently endorsed 
the need for information regarding services, their benefit, and insurance coverage than did 
higher SES parents. Further, the authors indicated that higher parent SES was associated with 
greater overall intervention use, mediated by knowledge of treatment options. Current results 
and those reported by Pickard and Ingersoll (2015) raise the question, could psychoeducation 
about the importance of research and its application in the field of ASD intervention alone be 
sufficient in decreasing use of non-evidence-based practice? Or is more general education and 
greater number of years of advanced schooling necessary? If there were a way to parse this 
apart in future studies, researchers could determine whether a psychoeducation intervention 
targeted at caregivers of children, implemented at first diagnosis of ASD, would be effective in 
reducing the use of dangerous treatments and/or treatments without evidence of benefit.  
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Further, the results indicated that child symptom severity of ASD did not significantly 
predict Hours CAM, which was predicted based on extant research suggesting this relationship 
(Christon, Mackintosh, & Myers, 2010; Hanson et al., 2007; Perrin et al., 2012). However, 
these studies used diagnosis as a proxy for severity. In contrast, when Siller, Reyes, Hotez, 
Hutman, and Sigman (2013) used ADOS scales as a measure of symptom severity of ASD, this 
measure did not predict intervention group. The relationship between ASD severity and use of 
CAM remains unclear, with the present study suggesting symptom severity does not have 
strong predictive power of use of CAM. Notably, this finding is consistent with the other study 
that used a validated measure of ASD severity rather than caregiver-reported diagnoses. This 
precision may be key in the difference in findings amongst studies of this relationship. Future 
examination of this relationship is needed and is likely to be more meaningful using a 
quantitative measure of severity, preferably based on both caregiver report and behavioral 
observations.   
In the second regression analysis, EBP Hours was the outcome variable. Results showed 
the model with predictors of child age, child symptom severity of ASD (based on ASD-DC 
total score), respondent income, and respondent education statistically significantly predicted 
EBP Hours, although the model accounted for only 12% of variance. Although there was a 
significant negative correlation between Hours EBP and respondent education, respondent 
education did not significantly contribute to prediction of Hours EBP when the other predictors 
were controlled for in the regression model. Rather, only child symptom severity of ASD 
contributed to the model in a statistically significant way. A positive regression coefficient 
indicated that as caregiver-reported symptoms increased, EBP Hours increased.  
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Arguably the most meaningful finding within the regression analyses was that 
significant predictors differed between CAM Hours and EBP Hours. The author suspected that 
education would predict less CAM use but more EBP use. The finding that respondent 
education predicted CAM Hours but not EBP Hours suggests that more highly educated 
respondents endorsed fewer hours of CAM, but did not endorse more hours of EBP. The author 
proposes that perhaps there is a ceiling effect in terms of EBP hours available. Certain CAM 
treatments may require no or less training than EBP treatments to provide to families, making 
them more widely available. In contrast, extant research suggests that lack of providers is a 
major barrier for families seeking interventions for ASD. For instance, Pickard and Ingersoll 
(2015) reported that 15% of parents in their sample indicated waitlists as a major barrier.  
Additionally, why would child symptom severity of ASD only predict EBP Hours and 
not CAM Hours?  One possibility could be that as ASD severity increases, insurance companies 
approve higher levels of EBP intervention provision. That is, a child with greater language 
impairment or with challenging behavior, both of which would be rated higher on the ASD-DC, 
may receive greater insurance coverage of EBP treatments (e.g., Speech Therapy, ABA). As 
lack of financial resources is frequently a barrier to children with ASD receiving treatment 
(Pickard & Ingersoll, 2015), insurance approval of EBP treatments is likely to increase access 
these services and thus increase endorsement. Further, despite ASD severity, insurance 
providers may be more hesitant to approve coverage of CAM treatments, increasing the 
likelihood these interventions be paid out of pocket.  
Given these regression models contributed to relatively small amounts of variance in 
CAM and EBP treatment hours (16% and 12%, respectively), what other factors beyond the 
predictors included could be contributing to these decisions? Because of small sample sizes, the 
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current study could not determine if source of information contributes to choice of CAM versus 
EBP, but extant research suggests it may (Deyro, Simon, & Guay, 2014; Miller et al., 2012). 
Another potential predictor could be comorbid problems and behaviors, particularly given the 
finding that CAM treatments are used for core symptoms of ASD as well as comorbid problems 
(Wong & Smith, 2006). Further analyses can be conducted to determine if problems such as ID, 
SIB, or physical aggression reported in the survey influence CAM Hours or EBP Hours when 
added to the model with the current predictors. Additionally, information regarding barriers to 
treatment was collected in the survey but is not included in the current study; however, barriers 
such as availability of providers, transportation to treatment, insurance coverage, etc. could all 
influence CAM Hours or EBP Hours. Based on results regarding these variables, such potential 
predictors could be entered into a larger model, given additional survey data is collected. 
Limitations 
The current survey had several limitations that would need to be remedied should the 
survey be administered again in the future. An online survey was selected for this study. The 
primary way the research project was advertised (i.e., social networks, email) and the way the 
survey was delivered inherently biases against respondents without reliable or consistent 
Internet access. This sampling bias could potentially be eliminated in the future by providing 
the survey in written form via mail-outs or in written form or via tablet or computer in health 
provider offices that serve more diverse populations (e.g., pediatrician offices that accept 
private insurance and Medicaid). Further, respondents “self-selected,” which likely means the 
respondents were highly motivated to participate in scientific research. Such individuals may 
be more highly educated or have better understanding of empirical evidence, which could bias 
the results.  
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 Nonetheless, online surveys have numerous advantages, including access to a large 
population, feasibility, lack of time constraints (i.e., 24 hour access), and completely voluntary 
participation (Riva, Teruzzi, & Anolli, 2003).  Fortunately, researchers suggest good 
equivalence between online surveys and paper-and-pencil surveys (Riva et al., 2003; Weigold, 
Weigold, & Russell, 2013). Nonetheless, survey questions could have been misinterpreted, 
such as the question about hours spent on CAM Group 3. Caregiver interviews would 
certainly be preferable over online or paper-and-pencil surveys for numerous reasons, 
primarily in terms of preventing problematic misinterpretation of questions. A research 
coordinator serving as an interviewer could clarify any confusion during administration and 
provide consistent definitions of treatments as needed. Such a project would likely require 
additional resources that were not available when the survey was created. 
Additionally, burden of time and lack of availability of any incentive may have 
prevented caregivers from beginning or completing the survey. There is a strong likelihood 
that this influenced the respondent demographics in that people who value research and who 
have more time to engage in research activities likely participated. The survey had a high 
drop-out rate (60% completed), which was likely due to the length of the survey and lack of 
incentive for completion. Researchers have suggested that, in studies of university students, 
10% drop out of online surveys instantaneously, with 2% additional dropout per 100 survey 
items (Hoerger, 2010). Comparing these percentages, there was significantly greater dropout 
in the current study than has been reported in extant research. However, the Hoerger (2010) 
surveys consisted of simple questions on easy topics (e.g., personality, mood), whereas the 
current study likely involved greater participant burden to complete. Of the 126 respondents 
who completed consent, 102 answered the first question (81%). As noted previously, there 
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was another significant dropout point at the first survey question that was about the child; only 
87 respondents answered the question about child age. Surprisingly, few respondents ceased 
answering questions when presented with the ASD-DC questions or the current treatment 
questions, which were time-consuming and potentially more burdensome than demographic 
questions and simple endorsements. Finally, a last significant dropout point was between the 
question regarding if there were any treatments the respondent wished the child received (75 
respondents) and the question addressing the barriers to obtaining these treatments (53 
respondents), despite the option of “I just have not gotten around to it yet, no real barriers.” 
Providing a small monetary reward may have enhanced motivation to begin and 
complete the survey. One drawback of providing a reward is the likelihood of duplicate 
responses; as such, IP addresses would need to be collected to prohibit respondents from 
completing the survey multiple times in order to receive the reward. Collection of IP addresses 
was not conducted during the current survey, and doing so would limit anonymity of 
respondents. 
Future Directions 
Despite these limitations, the survey provided preliminary data that suggests future 
research on these topics is worthwhile. Source of information and its ability to predict CAM 
versus EBP use needs further examination. Should information from certain individuals or 
groups be more predictive of unsupported treatment use, these sources could be targeted for 
further education. Caregivers who seek information from other caregivers of children with ASD 
may be doing so because they do not perceive themselves as having better sources. In this case, 
the author would not suggest the caregivers discontinue communication with other caregivers, 
as the emotional support and sense of belonging in such a group is important. Instead, the 
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caregivers could be educated about the myriad sources of misinformation regarding treatments 
and be directed to more reliable sources. Professionals assigning the initial ASD diagnosis or 
those who provide ongoing services and have established rapport could facilitate this 
discussion. 
 Further studies are needed to confirm that caregiver education is inversely related to 
CAM use. Should this finding continue to be replicated, there may be various manners in which 
to intervene. The author would prioritize the establishment of a comprehensive online resource 
that provides evidence on ASD treatments and potential negative outcomes of CAM treatments 
in an easily navigable and comprehended manner. Such a resource does not seem to be 
available at this time. For instance, the CDC website offers information about treatment 
classified as “Behavior and Communication Approaches,” “Dietary Approaches,” 
“Medication,” and “Complementary and Alternative Medicine.” As a government agency, the 
CDC presumably would be a relatively reliable and trustworthy source, yet it groups together 
EBP (e.g., ABA) with unsupported treatments (e.g., Floortime, Sensory Integration Therapy). 
Notably, the CDC’s examples of CAM include special diets, chelation, secretin, and deep 
pressure but do not mention that some of the treatments listed within the “Behavior and 
Communication Approaches” category are not supported treatments for ASD at this time. An 
ideal website would discuss the importance of scientific research and empirical evidence, 
provide categories of evidence base like the National Standards Project, and facilitate 
acquisition of empirically supported interventions (e.g., listing of service providers and their 
contact information, perhaps sorted by zip code). As noted, all of this information would need 
to be presented in an easily navigable format with a low reading level. 
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Additionally, the resources available on this website could be provided within a support 
group setting. A pilot program could be initiated that provides weekly meetings for caregivers 
of newly diagnosed children with ASD. Program coordinators, ideally psychologists in the field 
of developmental disabilities, could meet with a small group of caregivers to provide 
psychoeducation about the diagnosis, level of support that may be needed, realistic expectations 
in terms of prognosis, evidence for treatments, etc., as well as field the numerous questions 
caregivers have in the first few months after initial diagnosis. The program coordinator could 
work closely with a care coordinator, perhaps a social worker with good awareness of treatment 
options available locally, to help families obtain the EBP services recommended by the 
psychologist. Such a program could be potentially valuable for caregivers with less advanced 
education who need more hands-on assistance in selecting and acquiring EBP treatment. 
Success of such pilot programs could be measured in terms of EBP Hours, ASD treatment 
outcomes (e.g., social gains, decreases in challenging behavior), and parental stress and 
acceptance. Should the programs prove successful, the psychologists working on the project 
could standardize the program to allow psychologists to provide such groups throughout the 
country. 
These two potential program ideas could certainly intervene against the barrier of lack 
of education or information that some caregivers face. However, further work needs to 
determine other predictors of CAM versus EBP use. Obviously there is a confluence of factors 
that affect treatment selection, and targeting each of these variables will be important to best 
assist families in choosing interventions that are most likely to result in improved outcomes for 
ASD. 
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Appendix 2. Survey 
 
Treatments for Autism 
CONSENT TO PARTICIPATE:  Thank you for your interest in the Autism Spectrum Disorders 
Caregiver Survey of Experiences, Interventions, and Resource Availability.  The experience of getting 
an Autism Spectrum Disorder (ASD) diagnosis and subsequently obtaining treatment services varies 
widely based on many factors, but it is not unusual for caregivers to report some difficulties obtaining 
services,  or feel overwhelmed at times in the process of deciding which interventions to pursue. The 
purpose of  this research is to learn more about the experiences of caregivers of individuals with ASD.   
For this study, we want to hear from primary caregivers of individuals with ASD. We want to learn 
more about YOUR experience navigating the path to diagnosis and treatment for your child. We are 
collecting this data to inform efforts to improve this process, making it easier to get effective services 
for individuals with ASD.  The procedure involves filling an online survey that will take approximately 
20-30 minutes. The survey questions will be about experiences related to assessment and interventions 
for Autism Spectrum Disorder. Your responses will be confidential and combined with the answers of 
other survey participants. To protect your privacy, we will not be collecting any information that could 
be traced to  you individually, and the survey software (Qualtrics) allows us to block IP addresses from 
being collected. All data is stored in a password protected electronic format on a secure server. The 
results of this study will be used for scholarly purposes only and may be shared with Louisiana State 
University representatives.  Your participation in this research study is voluntary. You may choose not 
to participate or withdraw from participation at any time (contact any of the investigators via email, 
below). Most questions will have a “prefer not to answer” or “not applicable” option. There is no 
incentive or payment for your participation, but we sincerely appreciate your contribution towards 
helping us understand how to improve services for individuals with ASD.   This research project being 
conducted by graduate students in Clinical Psychology at Louisiana State University. If you have any 
questions about this research, you can contact Lindsey Williams at lwil175@lsu.edu, Hilary Adams at 
hadam15@lsu.edu, or Dr. Johnny Matson at psmats@lsu.edu.  This research has been reviewed and 
approved according to Louisiana State University Institutional Review Board procedures for research 
involving human subjects. Questions about subjects' rights or other concerns can be directed to Dennis 
Landin, PhD, Chairman, Institutional Review Board, (225) 578-8692, irb@lsu.edu, or via 
www.lsu.edu/irb. 
 
ELECTRONIC CONSENT: Please select your choice below.  Clicking on the "agree" button below 
indicates that: 
• you have read the above information 
• you voluntarily agree to participate 
• you are at least 18 years of age 
If you do not wish to participate in the research study, please decline participation by clicking on 
the "disagree" button. 
 
Please select one option below. 
mm I AGREE (1) 
mm I DISAGREE (2) 
 If I DISAGREE Is Selected, Then Skip To End of Survey   
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Autism Spectrum Disorder Caregiver Survey of Experiences, Interventions, and Resource Availability 
By Hilary Adams, MA and Lindsey Williams, MA 
 
Q1 How did you learn about this survey? 
 
Q2 What is your relationship to the individual with Autism Spectrum Disorder (ASD)? 
mm Biological mother (1) 
mm Biological father (2) 
mm Adoptive mother (3) 
mm Adoptive father (4) 
mm Other (Please type below.) (5) ____________________ 
 
Q3 What is your ethnicity? 
mm Caucasian (1) 
mm Latino (2) 
mm Middle Eastern (3)  
mm African American (4) 
mm Caribbean (5) 
mm South Asian (6) 
mm East Asian (7) 
mm Combination (Please type below.) (8) ____________________ 
mm Other (Please type below.) (9) ____________________ 
mm Prefer not to answer (10) 
 
Q4 What is your gender? 
mm Identify as male (1) 
mm Identify as female (2) 
mm Prefer not to answer (3) 
 
Q5 What is the highest level of education you have completed? 
mm Some high school (1) 
mm High school graduate (2) 
mm Technical, associate, or professional degree (3) 
mm Some college (4) 
mm College graduate (5) 
mm Some graduate school (6) 
mm Graduate degree (e.g., Masters or above) (7) 
mm Prefer not to answer (8) 
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Q6 What is your annual household income (US $)? 
mm Less than 10,000 (1) 
mm 10k-25k (2) 
mm 25k-40k (3) 
mm 40k-55k (4) 
mm 55k-70k (5) 
mm 70k-100k (6) 
mm More than 100k (7) 
mm Prefer not to answer (8)  
 
Q7 What is your current marital status? 
mm Single, never married (1) 
mm Married or in long-term relationship (2) 
mm Separated or divorced (3) 
mm Widowed (4) 
mm Other (Please type below.) (5)    
mm Prefer not to answer (6) 
 
Q8 What state do you live in currently? 
mm Alabama (1) 
mm Alaska (2) 
mm Arizona (3) 
mm Arkansas (4) 
mm California (5) 
mm Colorado (6) 
mm Connecticut (7) 
mm Delaware (8) 
mm Florida (9) 
mm Georgia (10) 
mm Hawaii (11) 
mm Idaho (12) 
mm Illinois (13) 
mm Indiana (14) 
mm Iowa (15) 
mm Kansas (16) 
mm Kentucky (17) 
mm Louisiana (18) 
mm Maine (19) 
mm Maryland (20) 
mm Massachusetts (21) 
mm Michigan (22) 
mm Minnesota (23) 
mm Mississippi (24) 
mm Missouri (25) 
mm Montana (26) 
mm Nebraska (27) 
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mm Nevada (28) 
mm New Hampshire (29) 
mm New Jersey (30) 
mm New Mexico (31) 
mm New York (32) 
mm North Carolina (33) 
mm North Dakota (34) 
mm Ohio (35) 
mm Oklahoma (36) 
mm Oregon (37) 
mm Pennsylvania (38) 
mm Rhode Island (39) 
mm South Carolina (40) 
mm South Dakota (41) 
mm Tennessee (42) 
mm Texas (43) 
mm Utah (44) 
mm Vermont (45) 
mm Virginia (46) 
mm Washington (47) 
mm West Virginia (48) 
mm Wisconsin (49) 
mm Wyoming (50) 
 
Q10 How would you describe the city/town where you currently live? 
mm Urban (50,000+ people) (1) 
mm Suburban (2,500 to 49,000 people) (2) 
mm Rural (less than 2,500 people) (3) 
 
Q37 How old is your child? (e.g., if your child turned 6 years old this month, put 6 years, 0 months; if 




Q38 What is your child's ethnicity? 
mm Caucasian (1) 
mm Latino (2) 
mm Middle Eastern (3)  
mm African American (4) 
mm Caribbean (5) 
mm South Asian (6) 
mm East Asian (7) 
mm Combination (Please type below.) (8) ____________________ 
mm Other (Please type below.) (9) ____________________ 
mm Prefer not to answer (10) 
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Q39 What is your child's gender? 
mm Identify as male (1) 
mm Identify as female (2) 
mm Prefer not to answer (3) 
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Q40 What is your child's current autism diagnosis? 
mm Autistic Disorder (1) 
mm PDD-NOS (Pervasive Developmental Disorder, Not Otherwise Specified) (2) 
mm Asperger’s Disorder/Syndrome (3) 
mm Autism Spectrum Disorder (4) 
mm Other (Please type below.) (5) ____________________ 
mm Not sure (6) 
 




Q42 Which, if any, difficulties did you experience when you were trying to get a diagnosis? (Select all 
that apply.) 
qq Long wait list for assessment (longer than 1 month) (1) 
qq Transportation problems (too far to drive, no easy access to transportation, etc.) (2) 
qq Scheduling problems (hard to get time off work, hard to arrange childcare for other children, etc.) (3) 
qq Insurance would not cover assessment (4) 
qq Insurance would cover part of assessment but out of pocket cost still too high (5) 
qq Caregivers were unsure or disagreed with one another about whether to get assessment (6) 
qq Professionals said assessment was not needed (said there was no problem, said child would “grow out 
of it”) (7) 
qq Other (Please type below.) (8) ____________________ 
 





Q44 Is your child currently taking prescribed medication meant to address symptoms related to autism, 
mood/anxiety, or Attention-Deficit/Hyperactivity Disorder? (Select all that apply.) 
qq Yes, currently taking medication for autism symptoms. (Please type below.) (1) 
____________________ 
qq Yes, currently taking medication for mood or anxiety symptoms. (Please type below.) (2) 
____________________ 
qq Yes, currently taking medication for Attention-Deficit/Hyperactivity Disorder. (Please type below.) 
(3)    
qq No, not currently taking medication for any of these reasons. (4) 
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Q45 My child... (Select all that apply.) 
qq Has received a diagnosis of Intellectual Disability (may be referred to as Mental Retardation in older 
reports) (1) 
qq Currently exhibits aggressive behavior toward other people (hitting, pinching, biting, etc.) (2) 
qq Currently exhibits self-injurious behavior (hurting self by head banging, biting self, etc.) (3) 
qq Has sleep problems on a regular basis (more nights than not; takes more than 30 minutes to go to 
sleep, wakes up frequently during the night, etc.) (4) 
qq Has received a diagnosis of seizure disorder or epilepsy (5) 
 
Q80 Rate each item for the extent that it is or was ever a problem. Compare the child to other children 
his/her age based on the following: 0 = Not different; no impairment 1 = Somewhat different; mild 
impairment 2 = Very different; severe impairment 
 
Q81 1. Communication skills. 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
 
Q83 2. Age appropriate self-help and adaptive skills (i.e., able to take care of self). 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
 
Q84 3. Engages in repetitive motor movements for no reason (e.g., hand waving, body rocking, head 
banging, hand flapping). 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
 
Q85 4. Verbal communication. 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
 
Q86 5. Prefers foods of a certain texture or smell. 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
 
Q87 6.  Ability to recognize the emotions of others. 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
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Q88 7. Maintains eye contact. 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
 
Q89 8.  Social interactions with others his/her age. 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
 
Q90 9. Response to others' social cues. 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
 
Q91 10. Use of language in conversations with others. 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
 
Q128 Rate each item for the extent that it is or was ever a problem. Compare the child to other children 
his/her age. 
 
Q92 11. Shares enjoyment, interests, or achievement with others (e.g., parents, friends, caregivers). 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
 
Q93 12. Ability to make and keep friends. 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
 
Q94 13. Interest in participating in social games, sports, and activities. 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
 
Q95 14. Interest in another person's side of the conversation (e.g., talks to people with intention of hearing 
what others have to say). 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
	  103 
Q96 15. Able to understand the subtle cues or gestures of others (e.g., sarcasm, crossing arms to show 
anger). 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
 
Q97 16. Use of too few or too many social gestures. 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
 
Q98 17. Body posture and/or gestures. 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
 
Q99 18. Communicates effectively (e.g., using words, gestures or sign language). 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
 
Q100 19. Displays a range of socially appropriate facial expressions. 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
 
Q101 20. Restricted interests and activities. 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
 
Q129 Rate each item for the extent that it is or was ever a problem. Compare the child to other children 
his/her age. 
 
Q102 21. Eye-to-eye gaze. 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
 
Q103 22. Reaction to sounds and sights. 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
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Q104 23. Walks or runs on toes/balls of feet (If unable to walk/run, rate "0"). 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
 
Q105 24. Reads nonverbal cues (body language) of other people. (If blind, rate "0") 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
 
Q106 25. Expects others to know their thoughts, experiences, and opinions without communicating them 
(e.g., expects others to "read his/her mind"). 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
 
Q107 26. Use of facial expressions. 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
 
Q108 27. Saying words and phrases repetitively (If nonverbal, rate "0"). 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
 
Q109 28. Make-believe or pretend play. 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
 
Q110 29. Understanding of age appropriate jokes, figures of speech, or sayings. 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
 
Q111 30. Gives subtle cues or gestures when communicating with others (e.g., hinting). 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
 
Q130 Rate each item for the extent that it is or was ever a problem. Compare the child to other children 
his/her age. 
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Q115 31. Becomes upset if there is a change in routine. 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
 
Q116 32. Needs reassurance, especially if events don't go as planned. 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
 
Q117 33. Language development. 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
 
Q118 34. Responds to others’ distress. 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
 
Q119 35. Socializes with other children. 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
 
Q120 36. Use of nonverbal communication. 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
 
Q121 37. Limited number of interests. 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
 
Q122 38. Development of social relationships. 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
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Q123 39. Isolates self (i.e., wants to be by him/her self). 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
 
Q124 40. Participation in games or other social activities. 
mm 0 = Not different; no impairment (1) 
mm 1 = Somewhat different; mild impairment (2) 
mm 2 = Very different; severe impairment (3) 
 
Q71 What type of insurance coverage does your child have? 
mm Private insurance only (such as through a caregiver's employer) (1) 
mm Medicaid or other public insurance (2) 
mm Both private insurance and Medicaid / public insurance (3) 
mm None (4) 
mm Not sure or prefer not to answer (5) 
 If None Is Selected, Then Skip To End of Block   
 
Q72 Does the insurance you indicated offer coverage for any autism treatment? 
mm Yes, and I am satisfied with the coverage. They provide adequate coverage for both the types services 
and the amount of those services that my child needs. (1) 
mm Yes, for some things, but I have had difficulty getting them to cover services, or they don’t provide 
the types of services I want. (2) 
mm No (3) 
mm Not sure (4) 
 
Q81  For the next few questions, we will be asking about types of treatments your child CURRENTLY 
receives. If you are unsure if your child receives a treatment, please do not select it. 
 
Q82 Does your child CURRENTLY use any of the following treatment(s)?· Early Intensive 
Behavioral  Intervention 
mm Yes (1) 
mm No (2) 
 
Q83 Does your child CURRENTLY use any of the following treatment(s)?· Applied Behavior 
· Natural Teaching Analysis (ABA) · Modeling· Pivotal Response Training 
Strategies 	   	  
mm Yes (1) 	   	  
mm No (2) 	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Q84 Does your child CURRENTLY use any of the following treatment(s)?· Cognitive  Behavioral 
Intervention  Package · Cognitive Behavioral Therapy 
mm Yes (1) 
mm No (2) 
 
Q49 Does your child CURRENTLY use any of the following treatment(s)?· Language Training 
(Production) · Speech therapy 
mm Yes (1) 
mm No (2) 
 
Q50 Does your child CURRENTLY use any of the following treatment(s)?· Parent Training· Peer 
Training Package· Self-Management  Training · Schedules 
mm Yes (1) 
mm No (2) 
 
Q51 Does your child CURRENTLY use any of the following treatment(s)?· Scripting· Social 
Skills Package · Story-Based Intervention (e.g., Social Stories) 
mm Yes (1) 
mm No (2) 
 
Q52 Does your child CURRENTLY use any of the following treatment(s)?· Alternative 
Communication  Devices· Functional Communication Training· Picture Exchange Communication 
System· Sign Instruction·  Facilitated  Communication· Music Therapy· Animal-assisted 
Therapy· Floor Time   · Play Therapy 
mm Yes (1) 
mm No (2) 
 
Q53 Does your child CURRENTLY use any of the following treatment(s)?· Exercise· Massage 
Therapy/Deep  Pressure· Auditory and/or Sensory Integration· Chiropractic· Art Therapy 
· Acupuncture 
mm Yes (1) 
mm No (2) 
 
Q54 Does your child CURRENTLY use any of the following treatment(s)?· Vitamins and 
supplements· Special or restricted diets (e.g., gluten-free, casein-free, yeast-free) 
· Oxytocin 
mm Yes (1) 
mm No (2) 
 
Q55 Does your child CURRENTLY use any of the following 
treatment(s)?· Chelation· Hyperbaric oxygen therapy (HBOT) · Packing 
mm Yes (1) 
mm No (2) 
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Q56 Does your child CURRENTLY use any of the following treatment(s)?· Occupational  therapy 
· Physical therapy 
mm Yes (1) 
mm No (2) 
 
Q57 Does your child CURRENTLY use any other treatment that you did not see above? 
mm Yes (Please type below.) (1) ____________________ 
mm No (2) 
 
Answer If Does your child CURRENTLY use any of the following treatment(s)? · Early Intensive 
Behavior... Yes Is Selected 
Q97 How many HOURS PER WEEK does your child spend receiving and/or using any of these 
treatments? ·  Early Intensive Behavioral Intervention 
______ Hours Per Week (1) 
 
Answer If Does your child CURRENTLY use any of the following treatment(s)? · Applied Behavior 
Analysi... Yes Is Selected 
Q51 How many HOURS PER WEEK does your child spend receiving and/or using any of these 
treatments? ·  Applied Behavior Analysis (ABA) · Modeling· Pivotal Response 
Training· Natural Teaching Strategies 
______ Hours Per Week (1) 
 
Answer If Does your child CURRENTLY use any of the following treatment(s)? · Cognitive 
Behavioral Int... Yes Is Selected 
Q52 How many HOURS PER WEEK does your child spend receiving and/or using any of these 
treatments? ·  Cognitive Behavioral Intervention Package· Cognitive Behavioral Therapy 
______ Hours Per Week (1) 
 
Answer If Does your child CURRENTLY use any of the following treatment(s)? · Language Training 
(Produ... Yes Is Selected 
Q53 How many HOURS PER WEEK does your child spend receiving and/or using any of these 
treatments? ·  Language Training (Production)· Speech therapy 
______ Hours Per Week (1) 
 
Answer If Does your child CURRENTLY use any of the following treatment(s)? · Parent Training 
· ... Yes Is Selected 
Q54 How many HOURS PER WEEK does your child spend receiving and/or using any of these 
treatments? ·  Parent Training· Peer Training Package· Self-Management 
Training· Schedules 
______ Hours Per Week (1) 
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Answer If Does your child CURRENTLY use any of the following treatment(s)? · Scripting 
· Social... Yes Is Selected 
Q55 How many HOURS PER WEEK does your child spend receiving and/or using any of these 
treatments? ·  Scripting· Social Skills Package· Story-Based Intervention (e.g., Social Stories) 
______ Hours Per Week (1) 
 
Answer If Does your child CURRENTLY use any of the following treatment(s)? · Alternative 
Communicatio... Yes Is Selected 
Q56 How many HOURS PER WEEK does your child spend receiving and/or using any of these 
treatments? ·  Alternative Communication Devices· Functional  Communication 
Training· Picture Exchange Communication System· Sign Instruction· Facilitated 
Communication· Music Therapy· Animal-assisted  Therapy· Floor Time· Play Therapy 
______ Hours Per Week (1) 
 
Answer If Does your child CURRENTLY use any of the following treatment(s)? · Exercise 
· Massage... Yes Is Selected 
Q57 How many HOURS PER WEEK does your child spend receiving and/or using any of these 
treatments? ·   Exercise· Massage Therapy/Deep Pressure· Auditory and/or Sensory 
Integration·  Chiropractic·  Art Therapy· Acupuncture 
______ Hours Per Week (1) 
 
Answer If Does your child CURRENTLY use any of the following treatment(s)? · Vitamins and 
supplements... Yes Is Selected 
Q58 How many HOURS PER WEEK does your child spend receiving and/or using any of these 
treatments? ·   Vitamins and supplements· Special or restricted diets (e.g., gluten-free, casein-free, 
yeast-free)·  Oxytocin 
______ Hours Per Week (1) 
 
Answer If Does your child CURRENTLY use any of the following treatment(s)? · Chelation 
· Hyperb... Yes Is Selected 
Q59 How many HOURS PER WEEK does your child spend receiving and/or using any of these 
treatments? ·  Chelation· Hyperbaric oxygen therapy (HBOT)· Packing 
______ Hours Per Week (1) 
 
Answer If Does your child CURRENTLY use any of the following treatment(s)? · Occupational 
therapy ·  ... Yes Is Selected 
Q60 How many HOURS PER WEEK does your child spend receiving and/or using any of these 
treatments? ·  Occupational  therapy· Physical therapy 
______ Hours Per Week (1) 
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Answer If Does your child CURRENTLY use any other treatment that you did not see above? Yes 
(Please type below.) Is Selected 
Q61 How many HOURS PER WEEK does your child spend receiving and/or using the OTHER 
treatment you indicated? 
______ Hours Per Week (1) 
 
Q153 Where do you get information about autism treatments? (Select all that apply.) 
qq Websites (1) 
qq Internet forum or online support group (2) 
qq Word of mouth from someone who is a caregiver of individual with ASD (3) 
qq Word of mouth from someone who is NOT a caregiver of individual with ASD (4) 
qq Doctor (pediatrician or primary care physician) (5) 
qq Magazines (6) 
qq Books (7) 
qq School/classroom teacher (8) 
qq ABA therapist (9) 
qq Occupational therapist (10) 
qq Physical therapist (11) 
qq Psychologist (12) 
qq Parent support group that meets in person (13) 
qq TV (14) 
qq Newspaper (15) 
qq Other (Please type below.) (16) ____________________ 
 
Q154 Of the sources of information about autism treatments you use, which is your most trusted source? 
 
Q175 Now you will again see some lists of interventions sometimes used for autism symptoms. Maybe 
your child currently uses some of these treatments; perhaps there are some he/she has never used. We 
would like to know if within each list of treatments you see any that your child used to use, but then quit 
using for some reason. There are 6 lists; some lists will be different than the lists you saw previously. 
 
Q176 For the following list please select any treatments your child used to use but then quit. You can 
select as many as apply in each list. (If none of these apply, select “none of the above.”) 
qq Applied Behavior Analysis (ABA) (1) 
qq Cognitive Behavioral Intervention Package (2) 
qq Cognitive Behavioral Therapy (3) 
qq Modeling (4) 
qq Pivotal Response Training (5) 





Q177 You said your child used to use but quit using the intervention(s) you selected. Why? Think about 
the treatment(s) he/she quit using from this list. Below, select any of the reasons for quitting the 
intervention(s) you just selected. 
qq Not seeing enough benefit from the treatment (1) 
qq Financial- out of pocket expense too great (2) 
qq My child was no longer eligible due to age or change in diagnosis (3) 
qq Change in insurance coverage (4) 
qq Took too much time or the scheduling was too inconvenient with other family obligations (5) 
qq Dissatisfied with the relationship with direct care providers (e.g., felt they were untrained, 
unprofessional, or inconsistent) (6) 
qq Did not like having service providers in my home (7) 
qq Proximity to my area- distance was too far to travel (8) 
qq My child’s behavior interfered with treatment at that time (for example, aggression, self-injury, 
refusal to get out of car) (9) 
qq Other (Please type below.) (10) ____________________ 
 
Q178 For the following list please select any treatments your child used to use but then quit. You can 
select as many as apply in each list. (If none of these apply, select “none of the above.”) 
qq Early Intensive Behavioral Intervention (1) 
qq None of the above (2) 
 
Answer If  None of the above Is Not Selected 
Q179 You said your child used to use but quit using the intervention(s) you selected. Why? Think about 
the treatment(s) he/she quit using from this list. Below, select any of the reasons for quitting the 
intervention(s) you just selected. 
qq Not seeing enough benefit from the treatment (1) 
qq Financial- out of pocket expense too great (2) 
qq My child was no longer eligible due to age or change in diagnosis (3) 
qq Change in insurance coverage (4) 
qq Took too much time or the scheduling was too inconvenient with other family obligations (5) 
qq Dissatisfied with the relationship with direct care providers (e.g., felt they were untrained, 
unprofessional, or inconsistent) (6) 
qq Did not like having service providers in my home (7) 
qq Proximity to my area- distance was too far to travel (8) 
qq My child’s behavior interfered with treatment at that time (for example, aggression, self-injury, 
refusal to get out of car) (9) 
qq Other (Please type below.) (10) ____________________ 
Answer If For the following list please select any treatments your child used to use but then quit. You can 
select as many as apply in each list. (If none of these apply, select none of the above. None of the above Is 
Not Selected 
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Q180 For the following list please select any treatments your child used to use but then quit. You can 
select as many as apply in each list. (If none of these apply, select “none of the above.”) 
qq Language Training (Production) (1) 
qq Natural Teaching Strategies (2) 
qq Parent Training (3) 
qq Peer Training Package (4) 
qq Schedules (5) 
qq Scripting (6) 
qq Self-Management Training (7) 
qq Social Skills Package (8) 
qq Speech therapy (9) 
qq Story-Based Intervention (e.g., Social Stories) (10) 
qq None of the above (11) 
 
Answer If  None of the above Is Not Selected 
Q181 You said your child used to use but quit using the intervention(s) you selected. Why? Think about 
the treatment(s) he/she quit using from this list. Below, select any of the reasons for quitting the 
intervention(s) you just selected. 
qq Not seeing enough benefit from the treatment (1) 
qq Financial- out of pocket expense too great (2) 
qq My child was no longer eligible due to age or change in diagnosis (3) 
qq Change in insurance coverage (4) 
qq Took too much time or the scheduling was too inconvenient with other family obligations (5) 
qq Dissatisfied with the relationship with direct care providers (e.g., felt they were untrained, 
unprofessional, or inconsistent) (6) 
qq Did not like having service providers in my home (7) 
qq Proximity to my area- distance was too far to travel (8) 
qq My child’s behavior interfered with treatment at that time (for example, aggression, self-injury, 
refusal to get out of car) (9) 
qq Other (Please type below.) (10) ____________________ 
 
Q182 For the following list please select any treatments your child used to use but then quit. You can 
select as many as apply in each list. (If none of these apply, select “none of the above.”) 
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qq Alternative Communication Devices (1) 
qq Exercise (2) 
qq Functional Communication Training (3) 
qq Massage Therapy/Deep Pressure (4) 
qq Music Therapy (5) 
qq Occupational Therapy (6) 
qq Physical Therapy (7) 
qq Picture Exchange Communication System (8) 
qq Sign Instruction (9) 
qq Structured Teaching (10) 
qq None of the above (11) 
 
Answer If  None of the above Is Not Selected 
Q183 You said your child used to use but quit using the intervention(s) you selected. Why? Think about 
the treatment(s) he/she quit using from this list. Below, select any of the reasons for quitting the 
intervention(s) you just selected. 
qq Not seeing enough benefit from the treatment (1) 
qq Financial- out of pocket expense too great (2) 
qq My child was no longer eligible due to age or change in diagnosis (3) 
qq Change in insurance coverage (4) 
qq Took too much time or the scheduling was too inconvenient with other family obligations (5) 
qq Dissatisfied with the relationship with direct care providers (e.g., felt they were untrained, 
unprofessional, or inconsistent) (6) 
qq Did not like having service providers in my home (7) 
qq Proximity to my area- distance was too far to travel (8) 
qq My child’s behavior interfered with treatment at that time (for example, aggression, self-injury, 
refusal to get out of car) (9) 
qq Other (Please type below.) (10) ____________________ 
 
 
Q184 For the following list please select any treatments your child used to use but then quit. You can 
select as many as apply in each list. (If none of these apply, select “none of the above.”) 
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qq Acupuncture (1) 
qq Animal-assisted Therapy (2) 
qq Art Therapy (3) 
qq Auditory and/or Sensory Integration (4) 
qq Chiropractic/osteopathy (5) 
qq Facilitated Communication (6) 
qq Floor Time (7) 
qq Oxytocin (8) 
qq Play Therapy (9) 
qq Special or restricted diets (e.g., gluten-free, casein-free, yeast-free) (10) 
qq Vitamins and supplements (11) 
qq None of the above (12) 
 
Answer If  None of the above Is Not Selected 
Q185 You said your child used to use but quit using the intervention(s) you selected. Why? Think about 
the treatment(s) he/she quit using from this list. Below, select any of the reasons for quitting the 
intervention(s) you just selected. 
qq Not seeing enough benefit from the treatment (1) 
qq Financial- out of pocket expense too great (2) 
qq My child was no longer eligible due to age or change in diagnosis (3) 
qq Change in insurance coverage (4) 
qq Took too much time or the scheduling was too inconvenient with other family obligations (5) 
qq Dissatisfied with the relationship with direct care providers (e.g., felt they were untrained, 
unprofessional, or inconsistent) (6) 
qq Did not like having service providers in my home (7) 
qq Proximity to my area- distance was too far to travel (8) 
qq My child’s behavior interfered with treatment at that time (for example, aggression, self-injury, 
refusal to get out of car) (9) 
qq Other (Please type below.) (10) ____________________ 
 
Q186 For the following list please select any treatments your child used to use but then quit. You can 
select as many as apply in each list. (If none of these apply, select “none of the above.”) 
qq Chelation (1) 
qq Hyperbaric Oxygen Therapy (HBOT) (2) 
qq Packing / Holding Therapy (3) 
qq None of the above (4) 
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Answer If  None of the above Is Not Selected 
Q187 You said your child used to use but quit using the intervention(s) you selected. Why? Think about 
the treatment(s) he/she quit using from this list. Below, select any of the reasons for quitting the 
intervention(s) you just selected. 
qq Not seeing enough benefit from the treatment (1) 
qq Financial- out of pocket expense too great (2) 
qq My child was no longer eligible due to age or change in diagnosis (3) 
qq Change in insurance coverage (4) 
qq Took too much time or the scheduling was too inconvenient with other family obligations (5) 
qq Dissatisfied with the relationship with direct care providers (e.g., felt they were untrained, 
unprofessional, or inconsistent) (6) 
qq Did not like having service providers in my home (7) 
qq Proximity to my area- distance was too far to travel (8) 
qq My child’s behavior interfered with treatment at that time (for example, aggression, self-injury, 
refusal to get out of car) (9) 
qq Other (Please type below.) (10) ____________________ 
 
Q188 For the following list please select any treatments your child used to use but then quit. You can 
select as many as apply in each list. (If none of these apply, select “none of the above.”) 
qq Other (Please type below.) (1) ____________________ 
qq None of the above (2) 
 
Answer If For the following list please select any treatments your child used to use but then quit. You can 
select as many as apply in each list. (If none of these apply, select &ldquo;none of the above.&rdq... 
Other (Please type below.) Is Selected 
Q189 You said your child used to use but quit using the intervention(s) you selected. Why? Think about 
the treatment(s) he/she quit using from this list. Below, select any of the reasons for quitting the 
intervention(s) you just selected. 
qq Not seeing enough benefit from the treatment (1) 
qq Financial- out of pocket expense too great (2) 
qq My child was no longer eligible due to age or change in diagnosis (3) 
qq Change in insurance coverage (4) 
qq Took too much time or the scheduling was too inconvenient with other family obligations (5) 
qq Dissatisfied with the relationship with direct care providers (e.g., felt they were untrained, 
unprofessional, or inconsistent) (6) 
qq Did not like having service providers in my home (7) 
qq Proximity to my area- distance was too far to travel (8) 
qq My child’s behavior interfered with treatment at that time (for example, aggression, self-injury, 
refusal to get out of car) (9) 
qq Other (Please type below.) (10) ____________________ 
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Q190 Is there any treatment you wish your child were currently receiving? If you select “yes", please tell 
us which treatment(s). 
mm No (1) 
mm Yes (2) ____________________ 
 
Answer If Is there any treatment you wish your child were currently receiving? If you select “yes", please 
tell us which treatment(s).<o:p></o:p> Yes Is Selected 
Q191 Think about the treatments you wish your child could receive right now. Which of the following 
problems are you facing right now? Select all that apply. 
qq Waitlists are too long (1) 
qq Distance- I have reliable transportation but the distance is just too far (2) 
qq Lack of Transportation- lack of reliable access to a vehicle and/or driver (3) 
qq Financial- out of pocket expense too great (4) 
qq Scheduling is too inconvenient for me / family (e.g., therapy time interferes with employment or other 
family obligations) (5) 
qq My child’s current treatments take so much time that I don’t want to add another at this time (6) 
qq I have tried or am trying to access this treatment, but the enrollment process is confusing/difficult (7) 
qq My child has challenging behaviors need to be addressed first (e.g., is aggressive, destructive, or runs 
away) (8) 
qq I just have not gotten around to it yet, no real barriers (9) 
qq Other (Please type below.) (10) ____________________ 
 
Q192 Now rank these problems in order, with 1 being the MOST frustrating or problematic. (Drag and 
drop items to put them in order.) 
 
End of Survey 
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